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Abstract
The Sustainable Development Goals (SDGs) call for an integrated response, the kind that has defined Neglected
Tropical Diseases (NTDs) efforts in the past decade.
NTD interventions have the greatest relevance for SDG3, the health goal, where the focus on equity, and its commitment
to reaching people in need of health services, wherever they may live and whatever their circumstances, is fundamentally
aligned with the target of Universal Health Coverage. NTD interventions, however, also affect and are affected by many of
the other development areas covered under the 2030 Agenda. Strategies such as mass drug administration or
the programmatic integration of NTD and WASH activities (SDG6) are driven by effective global partnerships
(SDG17). Intervention against the NTDs can also have an impact on poverty (SDG1) and hunger (SDG2), can
improve education (SDG4), work and economic growth (SDG8), thereby reducing inequalities (SDG10). The community-led
distribution of donated medicines to more than 1 billion people reinforces women’s empowerment (SDG5), logistics
infrastructure (SDG9) and non-discrimination against disability (SDG16). Interventions to curb mosquito-borne NTDs
contribute to the goals of urban sustainability (SDG11) and resilience to climate change (SDG13), while the safe use of
insecticides supports the goal of sustainable ecosystems (SDG15). Although indirectly, interventions to control water-
and animal-related NTDs can facilitate the goals of small-scale fishing (SDG14) and sustainable hydroelectricity and
biofuels (SDG7).
NTDs proliferate in less developed areas in countries across the income spectrum, areas where large numbers of people
have little or no access to adequate health care, clean water, sanitation, housing, education, transport and information. This
scoping review assesses how in this context, ending the epidemic of the NTDs can impact and improve our prospects of
attaining the SDGs.
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Background
The 17 goals of the SDG agenda integrate all three dimen-
sions of sustainable development: the economic, social
and environmental, around the themes of people, planet,
prosperity, peace and partnership. Following on from the
Millennium Development Goals (MDGs), the Sustainable
Development Goals (SDGs) prioritize the fight against
poverty and hunger, while also focusing on human rights
for all, and the empowerment of women and girls as part
of the momentum to achieve gender equality. They also
build upon the MDGs in order to address the “unfinished
business” of the MDG timeframe. The SDGs recognize
that eliminating poverty and inequality, creating inclusive
economic growth and preserving the planet are inextric-
ably linked, not only to each other, but also to the health
of populations. They also acknowledge the dynamic and
reciprocal relationships between each of these elements.
For example, a fundamental assumption of the SDGs is
that health is a major contributor and beneficiary of sus-
tainable development policies [1].
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The Neglected Tropical Diseases (NTDs) are a diverse
group of 17 human and zoonotic diseases whose health
and economic burden falls most heavily on the poorest
people and communities [2] NTDs include diseases such
as soil-transmitted helminths (STH), lymphatic filariasis,
onchocerciasis and schistosomiasis, as well as dengue
and rabies to list a few. Within the SDGs, the NTDs
have been included as a target to “end the epidemic of
NTDs by 2030” [3], an important achievement since the
inception of this grouping of diseases [4, 5], which have
been recently described as a “chronic pandemic” affect-
ing many millions [6]. Requirement for mass and indi-
vidual treatment or care for NTDs, a proxy indicator of
NTD prevalence, offers important insights into the way
the NTD burden is shared. In 2014, at least 1.7 billion
people required mass or individual treatment and care
for NTDs in 185 countries. Of these, 1.1 billion were in
lower- or middle-income countries. This is not to min-
imise the burden in the least developed countries. All
low-income countries are affected by at least five NTDs
[2], while the 520 million people requiring treatment in
low-income countries represent a staggering 60% of
those countries’ populations.
The NTDs and responses to them have the most dir-
ect relevance for the health goal, but they also have wide,
cross-cutting and cross-sectoral linkages and effects that
make them relevant to all the SDGs [7]. Thus efforts to
mitigate their impact will have a direct influence on
overall SDG progress [8].
Main text
SDG 1. End poverty in all its forms everywhere
SDG 1 is among the most ambitious of the 17 goals.
According to the 2030 Agenda, ending poverty in all
forms and dimensions by 2030 involves targeting those
living in vulnerable situations, increasing access to basic
resources and services, and supporting communities af-
fected by conflict and climate-related disasters. Rates of
extreme poverty have declined by more than half since
1990, in part, as a result of the rebalancing of global
trade towards Asia. However, one in five people in devel-
oping regions still live on less than $1.25 a day, and
there are millions more who survive on little more than
this daily amount. The 2030 Agenda underlines the fact
that poverty is more than the lack of income and re-
sources to ensure a sustainable livelihood.
The disabling and debilitating effects of NTDs pre-
vents adults from providing for their families and
contributing to the economic development of their
countries, and generates a significant care burden. At
the household level, this results in generations becoming
trapped in a cycle of increased medical costs, poverty
and disease. The so-called medical poverty trap affects
people worldwide, examples including countries such as
Cambodia and Viet Nam, where 50–67% of affected
households have incurred debt as a result of treatment
for dengue [9], or in Bangladesh [10] and Nepal [11],
where 25–75% of households affected by visceral leish-
maniasis experience some type of financial catastrophe
in obtaining a diagnosis and treatment. NTDs are a
financial burden on patients even when tests and medi-
cines are provided free of charge [12, 13], highlighting
the impact these diseases have beyond clinical care. The
impact of NTDs on the workforce can be enormous.
The chikungunya epidemic on Reunion Island resulted
in 112 400 lost days of work from 12 800 cases, costing
an estimated $18 million [14]. Families also pay a heavy
price in the form of out-of-pocket costs incurred at the
time of seeking care for treatment. In Ghana, the cost of
care per patient with Buruli ulcer in a household in the
poorest earning quartile can be as high as 315% of an-
nual earnings [15]. Similarly, in Nigeria the cost of
Buruli Ulcer care and diagnosis can be on average 162%
of patient’s median monthly household income, leading
to catastrophic financial loss [16]. The cost of NTDs is
not limited to human infections. Pigs are frequently kept
as a cash reserve to be used in an emergency such as for
medical needs. A study in Tanzania measuring the
impact of cysticercosis infections on these “cash re-
serves” found a significant economic burden resulting
from the reduced value or condemnation of pigs har-
bouring cycticercosis [17].
It is important to note that NTDs are diseases of pov-
erty rather than diseases of poor countries. Their impact
is felt by poor communities everywhere, including those
living in wealthy countries. Indeed, many of the highest
disease burden NTDs (just five NTDs represent 71% of
the total NTD burden [18]) occur predominantly in the
largest emerging market economies that comprise the
group of 20 nations (G20), in addition to Nigeria, which
also has one of the world’s largest economies [19]. Brazil,
China, India, Indonesia, and Nigeria have the largest
NTD prevalence, but even very wealthy nations, such as
the United States of America (USA), have a hidden
burden of NTDs, mostly concentrated in the southern
states [20] as well as Australia, where blinding trach-
oma and scabies remain a major public health prob-
lems in Aboriginal communities [21]. In Europe, the
Mediterranean basin is endemic for leishmaniasis
[22]. Autochthonous outbreaks of dengue have also
been reported in high-income countries of Portugal
[23], France [24], Australia, USA, Singapore and
Chinese Taipei [25] whilst recently a focus of urogeni-
tal schistosomiasis transmission (due to Schistosoma
haematobium) was found in Corsica, France [26].
NTD programmes play an important role in reducing
the financial burden on families seeking care both in the
way interventions are delivered (i.e., free of charge and
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often through community directed interventions) and by
placing greater emphasis on preventive care. Simply by
preventing the development of disease, NTD pro-
grammes reduce exposure to the debilitating physical
and mental health effects of NTDs [27] which give rise
to catastrophic and impoverishing costs [28]. It seems
clear, therefore, that progress on alleviating the burden
of NTDs is a prerequisite for progress towards SDG 1.
SDG 2. End hunger, achieve food security and improved
nutrition and promote sustainable agriculture
SDG 2 aims to end all forms of hunger and malnutrition
by 2030, ensuring that everyone, but especially children
and the more vulnerable, have access to sufficient, nutri-
tious food year round thereby ensuring food security.
This will require promoting sustainable agricultural
practices, improving the livelihoods and capacities of
small-scale farmers, allowing equal access to land, tech-
nology and markets. It will also require international
cooperation to ensure investment in infrastructure and
technology to improve agricultural productivity.
NTDs have an impact on nutrition both directly and
indirectly. Direct impacts include parasites such as
soil-transmitted helminthiases (STH) consuming the
nutrients required to keep people healthy [29]. These
helminths compete for nutrients within the host and will
naturally reduce the impact of food aid and other forms of
nutritional transfers. The nutritional impairment caused
by schistosome and STH infections during childhood
has been shown to have an impact on the growth
and development of children [30]. Anaemia and mal-
nutrition are common side effects of several NTDs
[31]. Food animals are also affected. Ruminants may
fail to put on weight as a result of helminth infections
[32], and cows produce up to 15% less milk as a result of
nematode infections [33]. Trypanosomiasis in domestic
animals, particularly in cattle, causes serious economic
losses in livestock from anaemia, loss of condition and
emaciation and is sometimes fatal resulting in loss of cap-
ital to poor livestock owners [34]. To a lesser extent, but
nonetheless frequently fatal, outbreaks from orally-
transmitted Chagas in fruit juices have affected food se-
curity in Venezuela [35].
Indirect impacts include the debilitating effects on
those living with disease, such as farmers who are less
able to work and thus produce the crops needed to feed
themselves and their families, and impoverished con-
sumers who are less able to pay for the food they need.
It is fitting that Guinea worm disease translates to ‘the
disease of the empty granary’ in Bambara, spoken by
Dogon people in Mali, since the peak transmission
period coincides with the harvesting season [36]. In
addition, trichiasis and onchocerciasis prevents women
from working, including fulfilling their traditional role as
primary food providers due to visual impairment [37],
making it difficult to work, socialise and even to walk
beyond their homes [38].
Controlling and eliminating NTDs thus contributes to
improving agricultural productivity, increasing food
security and the nutritional status of affected communi-
ties. Cost-effective interventions of proven efficacy
include the periodic deworming of children [39] together
with improvement of water and sanitation [40], and
health education [41], all of which have been shown to
reduce the transmission of schistosome and soil-
transmitted helminth infections [42–44]. The World
Health Organization (WHO) recommends periodic
treatment with anthelminthic (deworming) medicines,
without previous individual diagnosis to all at-risk
people living in endemic areas, including, preschool and
school-aged children, and women of childbearing age,
including pregnant women in the second and third tri-
mesters and breastfeeding women. Treatment should be
given once a year when the prevalence of STH infections
in the community is over 20%, and twice a year when
the prevalence of STH infections in the community
exceeds 50%. The latest meta-analysis on de-worming
and child nutrition confirms the consensus view regard-
ing cost effectiveness of mass drug administration
(MDA) [45].
With regard to agriculture, evidence of the beneficial
impact of NTD interventions on nutrition include a
study carried out in 2014 which shows that the 600 mil-
lion people dependent on healthy livestock affected by
zoonotic NTDs, such as cysticercosis, would derive mul-
tiple benefits by integrating sustainable management of
helminth infections into the whole-farm economic con-
text using a combination of helminth laboratory diag-
nostics and animal health economics. The study
concluded that benefits would include increases in the
safety and quality of food and an increased return on in-
vestment in food security [32].
SDG 3 Ensure healthy lives and promote well-being for all
The health goal, the goal for which NTDs and NTD pro-
gress have the greatest relevance is discussed at length
elsewhere [46]. Here, we limit ourselves to noting that
the health goal has 13 targets, several of which are more
or less direct transfers from the MDGs, but that the tar-
get for infectious diseases (3.3) has been expanded to in-
clude hepatitis, waterborne infections, and the NTDs.
Passed over in the MDGs as “other diseases”, NTDs
have now been accorded a specific target, reflecting their
importance in terms of global prevalence and their so-
cial, economic and developmental consequences.
One important addition to the health goal of the SDGs
is the inclusion of the Universal Health Coverage (UHC)
target (3.8), the only target that cuts across all targets of
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the health goals, as well as addresses linkages with
health-related targets in the other goals. Ensuring that
essential services reach all those who need them is at the
heart of NTD response efforts and is a fundamental
component of WHO’s “Roadmap for implementation” of
the 2012 NTD Strategy [47] endorsed by the World As-
sembly Resolution of 2013 [48]. Economists from 44
countries have called on global policy makers to priori-
tise a pro-poor pathway to universal health coverage
(UHC) as an essential pillar of development [49]. NTD
strategies, programmes and interventions are closely
aligned with UHC goals or have components that have
relevance for UHC. These include: defining and deliver-
ing an essential package of quality interventions across
the full continuum of services; expanding coverage of
services to ensure they reach all who need them; and
providing financial protection to minimize out-of-pocket
(OOP) payments and financial hardship. The notion of
equitable access is woven into the fabric of the NTD
agenda, serving as a constant reminder that cost-
effectiveness is not the sole criterion for prioritisation of
services, and that explicit consideration must be given to
the most disadvantaged groups, including the low-
income, rural and marginalised communities most at
risk of NTDs.
SDG 4 Ensure inclusive and equitable quality education
and promote lifelong learning opportunities for all
Since 2000, there has been significant progress in achiev-
ing the target of universal primary education. The total
enrolment rate in developing regions reached 91% in
2015, and the worldwide number of children out of
school worldwide has dropped by almost half. There has
also been a dramatic increase in literacy rates and many
more girls are in school now than ever before. However,
despite these advances, challenges remain, and, going
forward, progress will depend on all girls and boys hav-
ing access to free, quality primary and secondary educa-
tion, and equal access to affordable vocational training.
It will also require equal access to all levels of education
and vocational training for the vulnerable, including
people living with disabilities, indigenous peoples and
children in vulnerable circumstances. The SDG focus on
achieving quality education for all reaffirms the belief
that education is one of the most powerful drivers of
sustainable development.
That NTDs have a direct impact on school attendance
and student performance is well established. For example,
multiple studies have described the impact of STH and
schistosome infections in children, reducing both school
performance and attendance [50–52]. As many as two bil-
lion people are estimated to suffer from intestinal worms
such as roundworm, hookworm, or whipworm [53], the
largest burden of disease being found in sub-Saharan
Africa and South Asia. STHs continue to have a major im-
pact on public health, particularly in rural communities
and particularly in regard to children’s school participation
[54] and cognitive ability [55]. The indirect effects of
NTDs on education, include the stigma and exclusion as-
sociated with disfiguring diseases [56].
Fortunately, a single dose of the inexpensive, safe and
easily administered drugs albendazole and mebendazole
is effective in the treatment of worms. The fact that the
drugs have no significant side effects for uninfected
children – and the fact that screening children for infec-
tion is much more expensive than treating them – has
pointed policymakers towards a policy of mass treatment
in high prevalence populations, including school age
children [57]. School attendance increases for several
reasons, some direct and related to morbidity. For ex-
ample, deworming has been shown to improve cognition
both in the short- and long-term (i.e., in communities
7–10 years after treatment) [58, 59].
School-based delivery of anthelminthics is one of the
most cost-effective interventions to boost school attend-
ance and performance as evidenced by a number of
studies highlighting their positive impacts on children’s
health, nutritional status, cognitive function and educa-
tional achievement [60]. A notable success story in this
respect is a school-based deworming programme in
Kenya which reduced absenteeism by 25%, and added a
year to the average duration of a child’s education [51].
A long-term study revealed that the impacts of school-
based deworming after 10 years included males staying
enrolled for more years of primary school, working 17%
more hours each week, spending more time in non-
agricultural self-employment, being more likely to hold
manufacturing jobs, and missing one less meal per week.
The same study showed women being approximately
one quarter more likely to have attended secondary
school, thus halving the gender education gap [61].
The verdict from this body of evidence is clear:
deworming treatment is not only highly effective and
inexpensive, it is easy to administer through schools and
brings benefits to children years after treatment [62].
There is a need to measure these benefits using robust
epidemiological methods [63], while avoiding the biases
such studies can entail [64, 65], in order to provide
adequate evidence to policy makers. Nevertheless, with
hundreds of millions of children still at risk of worm
infection worldwide, providing free school-based
deworming treatment is an easy policy “win” for health,
education, and development.
SDG 5. Achieve gender equality and empower all women
and girls
Ending discrimination against women and girls is not
only the fulfilment of a basic human right, but has
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implications for all SDG development areas. The last
15 years have seen some progress. For example, more
girls are now in school compared to the year 2000, and
most regions have reached gender parity in primary edu-
cation. Women now make up to 41% of paid workers
outside of agriculture, compared to 35% in 1990. The
SDGs aim to build on these achievements to ensure that
there is an end to discrimination against women and
girls everywhere. The areas of focus are: access to paid
employment; unequal treatment of women in the labour
market; sexual violence and exploitation; harmful trad-
itional practices such as child, early and forced marriage
and female genital mutilation; ensuring universal access
to sexual and reproductive health; affording women
equal rights to economic resources such as land and
property; and encouraging women leaders across all
regions to strengthen policies and legislation for greater
gender equality.
While NTDs impose a heavy burden on both sexes,
there has been increasing recognition of the dispropor-
tionate impact of some NTDs on the health of girls and
women [66]. Schistosomiasis is a matter of particular con-
cern. Whether or not women are more exposed to schis-
tosomiasis infection than men is unclear, evidence having
been presented on both sides of the argument. On the one
hand Huang and co-workers pointed out that the social
and occupational roles may place men at an increased risk
of acquiring certain NTDs, including schistosomiasis [67].
Whilst McDonald and co-workers found that gendered
division of household tasks means that women and girls
are usually in charge of washing clothes and collecting
water and thus more exposed to contaminated water, and
therefore schistosomiasis and other water-borne infections
[68]. However, there can be little debate regarding the im-
pact of schistosomiasis infection on pregnant women, with
urogenital schistosomiasis [69, 70] being a common
gynaecologic condition among African women [71], a sig-
nificant cause of pregnancy complications [66, 72, 73] with
an increased risk of HIV transmission in women due to
the presence of genital lesions [74, 75]. Pregnant women
also suffer from hookworm-associated anaemia and den-
gue in pregnancy [76, 77]. More recently, the impact of
Zika virus causing congenital birth defects, including
microcephaly and other neurological sequelae and
Guillain-Barré syndrome has emerged [78]. While Zika is
not yet formally recognized as an NTD, it has already be-
ing discussed in that framework [79]. Women are also
susceptible to mother-to-child transmission of Chagas
disease [80], among other conditions [81]. There is also
some evidence that co-infection with Plasmodium falcip-
arum and helminths affect predominantly school-age
children and pregnant women. These groups, which have
the highest risk of anaemia, would benefit from an inte-
grated approach to malaria and helminth control [82].
Finally, women’s disproportionate poverty, illiteracy,
lack of education, land ownership and political voice act
as barriers to health-seeking, and may increase their ex-
posure to NTDs and their sequelae [68]. In this context,
the empowerment of women becomes a crucial aspect
of the fight against NTDs, and interventions focused on
NTD control and elimination offer important opportun-
ities for improving the health and rights of girls and
women in the populations affected [66].
With regard to specific NTD interventions, it has been
demonstrated that treatment of women for hookworm
in the second and third trimester increases infant sur-
vival in hookworm endemic areas [83]. One study,
examining the association between anthelminthic treat-
ment with the drug albendazole and maternal anaemia,
birth weight, and infant mortality, revealed that women
given albendazole in the second trimester had a lower
rate of severe anaemia during the third trimester. Birth
weight of infants of women who had received two doses
of albendazole rose by 59 g, and infant mortality at
6 months fell by 41%. Thus, it appears that antenatal
anthelminthic treatment is effective at reducing maternal
anaemia and improving birth weight and infant survival
in hookworm-endemic regions. In addition praziquantel
used in schistosomiasis MDA can also be safely used in
pregnancy thereby improving anaemia status of infected
women [83].
There is also some evidence of proportionately greater
benefit for women of MDA. For example, coverage sur-
veys from 37 countries, showed a gender ratio slightly in
favour of women (between 0.96 and 1.17) [84], an obser-
vation confirmed by data from Uganda [85]. Qualitative
data collected from district health workers, community
leaders, community medicine distributors and commu-
nity members suggested that socio-behavioural and
structural barriers to treatment access may be present
for both genders. However, where Community Directed
Distribution (CDD) was introduced, an increasing num-
ber of women attended meetings, spoke out and were
then selected as community implementers. Over time,
women also became more outspoken, participated more
actively, and demanded to be assigned responsibilities.
Community-based organizations, including women’s
groups, became more involved in the process. For in-
stance, in one Nigerian site, the market women’s associ-
ation now plays an active role in community health
activities [86]. Many community members have also
reported that women were more committed, persuasive
and more patient than men in the distribution of iver-
mectin [87].
SDG 6 Ensure access to water and sanitation for all
Progress on water and sanitation has been remarkable
over recent decades, with an estimated 2.1 billion people
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gaining access to an improved water source since 1990.
According to the most recent data, nearly 90% of the glo-
bal population has access to an improved water source,
which means water that is either piped into a dwelling,
plot or yard, obtained from a public tap, or well, or col-
lected from a protected spring or rainwater [88]. Unfortu-
nately, this still means that around 633 million people do
not have access to an improved drinking water source,
while access does not mean that the water being collected
is necessarily clean. A recent literature review reported
that in 38% of 191 studies, over a quarter of samples from
improved sources contained faecal contamination [89].
Meanwhile, an estimated 40% of people around the world
are affected by water scarcity, a number that is projected
to increase with the rise of average global temperatures.
Progress on sanitation has been even less impressive, with
36% of the world’s population, or nearly 2.5 billion people,
lacking access to improved sanitation facilities putting
them at risk of enteric diseases including dysentery, chol-
era, typhoid, schistosomiasis, and intestinal worms. [88]
Ensuring universal access to safe, reliable and afford-
able drinking water by 2030 requires investment in infra-
structure to support the provision of sanitation facilities,
and investments in efforts to support behavioural
change, discouraging, in particular, the widespread prac-
tice of open defecation. It will also require protecting
and restoring water-related ecosystems such as forests,
mountains, wetlands. Greater international cooperation
is also needed to encourage water efficiency and support
of treatment technologies in developing countries [90].
NTD programmes and initiatives have a privileged role
to play in achieving those goals because of the prime im-
portance of water and intermediate hosts in the lifecycle
of many pathogens. NTDs thrive where water and sanita-
tion are inadequate. For example, water contaminated
with faeces and urine can contain worm eggs that contam-
inate surface water and lead to transmission of schisto-
somiasis. These can come from the faeces and urine of
human and reservoir hosts, such as cows and buffalos,
making it important to protect freshwater from animals
and their waste. Poorly-constructed latrines facilitate the
breeding of Culex mosquitoes, causing great nuisance as
well as being efficient vectors of lymphatic filariasis and
some viruses [91]. Replacement of pit latrines with mod-
ern toilets would contribute to a reduction in nuisance
biting and transmission reduction [92]. Similarly, Ae-
des aegypti, the major vector of arboviruses, could be
reduced by environmental management. This urban
species breeds in many small uncontaminated water
bodies [93]. In many cases where piped water is lack-
ing or unreliable, water-storage containers become
major larval habitats for Ae. aegypti and Ae. albopic-
tus mosquitoes which transmit dengue, Zika, yellow
fever and chikungunya viruses to humans.
Meanwhile, access to clean water is essential for tack-
ling some diseases. For example, trachoma, a leading
cause of preventable blindness, is caused by a bacterial
(Chlamydia trachomatis) infection transmitted through
contact with eye-seeking flies (Musca sorbens, a fly
closely associated with breeding in human faeces), dirty
fingers and fomites. Facial cleanliness and environmental
improvement are primary prevention components of
WHO’s SAFE strategy for trachoma elimination [94], re-
quiring clean water for face washing to remove eye
discharges. Unfortunately, the people affected by NTDs
are often stigmatized and can be excluded from acces-
sing water and sanitation facilities, increasing their risk
of poverty and severe illness [56].
Water, sanitation and hygiene (WASH) interventions
are essential components in preventing many NTDs, as
attested by individual studies, reports and systematic
reviews. The work of the Guinea Worm Eradication
Programme’s (GWEP) in assisting in the provision of in-
creased access to safe water through provision of bore
holes and protected wells is notable in this regard. [95]
Other studies conclude the development and manage-
ment of water resources is vital in schistosomiasis con-
trol [96] and that individual household latrines are
associated with lower STH infection versus shared sani-
tation facilities [97].
Various systematic reviews have been published with
findings that include: safe water being associated with
significantly reduced chance of Schistosoma infection
and access to adequate sanitation being associated with
significantly lower odds of infection with both S. man-
soni and S. haematobium [98]; better hygiene in children
being associated with lower odds of developing trach-
oma and access to sanitation being associated with 15%
lower odds of active trachoma and 33% lower odds of C.
trachomatis infection of the eyes [99]; and WASH access
and practices being associated with 33–70% lower odds
of STH infection (people who wash their hands after
defecating are less than half as likely to be infected as
those who did not) [100].
Reflecting the cross-sectoral nature of the WASH
challenge, and the fact that the WASH component of
the NTD strategy has not received attention in line with
its importance, in August 2015 the WHO launched a
global strategy and action plan to integrate WASH with
other public health interventions [101]. The expectation
is that a more integrated approach to NTDs and WASH
efforts will increase efficiencies and enhance sustainabil-
ity. It will also ensure that investments in WASH reach
those most in need. Achieving universal access to
WASH requires a focus on the poorest and hardest to
reach, the same groups most affected by NTDs. How-
ever, the target date for the WHO NTD roadmap is
2020, 10 years earlier than WASH, (the WASH sector is
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focused on the SDG target of universal access to basic
WASH in communities, schools and healthcare facilities
by 2030). Integration may thus add impetus to the need
for progress on the WASH agenda for the most vulner-
able. Only the achievement of the WASH targets will
ensure that sustained reduction of transmission of those
NTDs associated with water and sanitation will be
achieved. Thus, progress on certain NTDs can also serve
as a proxy for equity and effective targeting of WASH
programmes. The joint strategy has the potential to
make an important contribution to global efforts to
achieve the SDGs, most notably in regard to the achieve-
ment of UHC whilst addressing some of the key deter-
minants of human health.
SDG 7. Ensure access to affordable, reliable, sustainable
and modern energy for all
According to the United Nation’s Development
Programme the number of people with access to electri-
city increased by 1.7 billion between 1990 and 2010.
While this represents an impressive advance in develop-
ment, since it is based almost exclusively on fossil fuels
it will increase greenhouse gas emissions, and has the
potential to exacerbate climate change. Thus the 2030
Agenda calls for a switch towards renewable energy such
as solar, wind and thermal, and for the adoption of cost-
effective standards for a wider range of technologies.
Expanding infrastructure and upgrading technology to
provide clean energy sources in all developing countries
is seen as a crucial goal that can both encourage growth
and help the environment.
In certain areas there is a significant degree of align-
ment between NTD and sustainable energy agendas. For
example, a move towards clean energy technologies such
as biogas systems, which produce methane from human
and animal waste, has the potential to provide immedi-
ate benefits for the control of NTDs. This was borne out
by an assessment of the parasitic disease and energy
benefits of biogas systems in Sichuan Province, China,
where the burning of effluent not only generated energy
in a sustainable way, but also inactivated the schistosom-
iasis eggs contained within [102]. This highlights ways in
which the public health sector can leverage the prolifera-
tion of rural energy projects as a part of infectious dis-
ease control.
Sustainable energy strategies that integrate rural en-
ergy needs and sanitation offer considerable promise for
the long-term control of parasitic diseases, while simul-
taneously reducing energy costs and improving quality
of life. Government policies can enhance the financial
viability of such strategies by introducing fiscal incen-
tives for joint sanitation/sustainable energy projects,
along with their associated public outreach and educa-
tion programs. [103] Meanwhile, zoonotic NTD control
programmes can contribute to such projects by targeting
those communities where the returns from biofuel gen-
eration are expected to be largest and in ensuring safe
access to reliable sources of biomass.
It can also be argued that efforts to mitigate the im-
pact of NTDs enhances the feasibility and sustainability
of hydroelectricity projects. For example, it has been
shown that the construction of large dams has led to
increases in human schistosomiasis in China, Cote
d’Ivoire, Egypt, Ethiopia, Senegal [104], and Sudan,
amongst others [105–107]. Dam spillways are known to
serve as breeding sites for blackflies [108], and the con-
struction of dams can lead to complex changes in habi-
tat, which in addition to movement of non-immune
populations and snails into the area can lead to trans-
mission hotspots [109]. Evidence for beneficial inter-
sectoral collaboration includes a study examining the
impact of dam construction in Senegal and Mali, which
showed the beneficial impact of control of water-related
NTDs, including control of snails and mosquitoes [109].
When initiating sustainable energy infrastructure, the
existence of good control interventions for NTDs can
ensure that the negative impact on health caused by
NTDs will be mitigated.
SDG 8. Promote inclusive and sustainable economic
growth, employment and decent work for all
Over the past 25 years, the number of workers living in
extreme poverty has declined steeply, despite the after-
shocks of the 2008–2009 financial and economic crisis.
However, sluggish global economic growth, widening
economic inequalities and employment that is not
expanding fast enough to keep up with the growing
labour force are significant sources of concern. Accord-
ing to the International Labour Organization, more than
204 million people were unemployed in 2015. The SDGs
aim to encourage sustained economic growth by achiev-
ing higher levels of productivity and through techno-
logical innovation. Promoting policies that encourage
entrepreneurship and job creation are key to economic
growth, as are effective measures to eradicate forced
labour, slavery and human trafficking. With these targets
in mind, the goal is to achieve full and productive
employment, and rewarding work, for all women and
men by 2030.
The economic effect of NTDs, taken together with the
social and psychological burden they impose is enor-
mous [110, 111]. The financial and economic costs of
treatment and control of NTDs are generally underesti-
mated because of the tendency to focus on the costs to
the health care system itself, and in particular the costs
faced by government-funded health facilities. Other costs
relate to lost productivity [112]. A study of tea pickers in
Bangladesh living with three worm infections (Ascaris
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lumbricoides, Trichuris trichiura, and hookworms),
showed a negative association between the intensity of
helminth infections (eggs and faeces) and productivity
[113]. Losses can also accrue because of households and
businesses adapting their activities in response to the
NTD burden. So-called coping strategies can lead to de-
creased savings and investment, lost capital and purchas-
ing power, and inefficient labour substitution [114].
Clearly, a healthy workforce is critical for economic
development. The disabilities, disfigurement and debili-
tating effects, including mental health impacts [27, 115],
of NTDs, as well as secondary impacts such as exclusion
and prejudice, prevent adults from working, providing
for their families and contributing to the economic de-
velopment of their countries. As noted in regard to SDG
1, at the household level, this can trap generations in a
cycle of increased medical costs, poverty and disease; at
the macro level it results in significant economic losses
for countries. Evidence for this includes a study of
lymphatic filariasis in India which showed that every
year $842 million are lost due to treatment costs and re-
duced working time, equivalent to $2 per person resi-
dent in endemic areas [116]. The global economic
burden of rabies is about $8.6 billion dollars lost [117],
while the economic burden of dengue in the Americas is
$2.1 billion dollars lost. [118] NTD programmes can
have a significant impact on individuals’ employment
prospects, and by extension, national productivity.
Evidence for this includes a study conducted in the
southern USA which estimated that childhood treatment
for hookworm increased future wages by approximately
40% [119], and the above-mentioned study covering the
long-term impact of deworming in Kenya, which showed
that future earnings are up to 29% higher for children
targeted by the campaign, while hours worked increased
by 12% and work days lost to illness decreased by a
third. A study undertaken in Egypt, showed that workers
with schistosomiasis increased productivity if they could
access early detection and treatment [120]. Thus, inter-
ventions to control NTDs promise significant economic
pay-offs outside the health sector in agricultural prod-
uctivity and educational benefit, and should be consid-
ered as investments in human capital and poverty
reduction [121]. A recent study has estimated that the
impact of MDA during the past 13 years prevented or
cured 96 million cases of lymphatic filariasis, despite 36
million cases of hydrocoele and lymphoedema remaining
[122]. However, the economic benefits estimated to have
accrued during the first 8 years of the programme
exceeded $24 billion. A 2016 study on health gains from
NTD programmes has estimated if targets are met for
nine NTDs, 600 million Disability Adjusted Life Years
(DALYs) would be averted, which can be extrapolated to
2030, due largely to the decline in morbidity of NTDs
treated by preventive chemotherapy [123]. However, this
figure does not include gains in subtle morbidities
through improved cognitive development and mental
health and the analysis was restricted to only nine
NTDs. This suggests that overall gains in DALYs from
all NTD programmes would be substantially greater
than the 600 million DALY figure, thereby having a
significant impact on economic growth of affected
communities.
SDG 9. Build resilient infrastructure, promote sustainable
industrialization and foster innovation
Sustained investment in infrastructure and innovation
are crucial drivers of economic growth and develop-
ment. SDG 9 targets the development of quality, reliable,
sustainable and resilient infrastructure, including re-
gional and trans-border infrastructure, to support
economic development and human well-being, with a
focus on affordable and equitable access for all. Key to
achieving this will be significantly raising industry’s share
of employment and Gross Domestic Product (GDP), in
line with national circumstances, an overall target that
includes doubling the share of industry in the employ-
ment and GDP of the least developed countries.
The drive to end NTDs has made a considerable con-
tribution to logistics infrastructure generally and particu-
larly at the community level. MDA has required the
development of, and investment in, supply chains,
including transport and storage infrastructure and the
clinics ensuring the availability of donated medicines
[86, 124]. The “Supply Chain Forum”, a landmark
private and public partnership consortium, has ensured
that endemic countries are able to efficiently request and
receive supplies for NTD interventions. This includes
the development of a tool to streamline supply chain
management, the creation of a dedicated DHL control
tower to facilitate clearance through customs and statis-
tical tools to forecast demand [125]. NTD programmes
and initiatives have also enhanced the capacity of labora-
tories to diagnose diseases [126], conduct independent
clinical research [127] and has led to the construction of
roads, markets, schools and clinics [128].
Health R&D encompasses the WHO strategy for re-
search and innovation in health and aims to develop
technologies (medicines, diagnostics, medical devices,
vaccines, etc.) for diseases, including the NTDs, that dis-
proportionately affect developing countries [129]. The
Visceral Leishmaniasis Global R&D and Access Initia-
tive, for example, addresses some of the critical R&D
gaps in order to provide supporting tools to meet the
WHO elimination goals for visceral leishmaniasis (VL).
These demonstration projects as part of the aim to end
the epidemic of NTDs, can serve as an example of how
innovation can be fostered beyond the NTDs.
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In order to address the under-representation of
African scientists in global priority setting for research
on NTDs, five European foundations (Volkswagen,
Gulbenkian, Mérieux, Nuffield and Cariplo foundations)
formed the European Foundation Initiative for African
Research into Neglected Tropical Diseases (EFINTD) in
2008 [130]. EFINTD has strengthened research capacity
in NTDs by empowering young African researchers who
are based in their home countries to perform research
on various NTDs [131] and has created the African
Network for NTDs (ARNTD).
SDG 10. Reduce inequality within and among countries
Increased global productivity, driven largely by product-
ivity gains in Asia, has contributed to the reduction of
global poverty levels. However, inequality persists, and
large disparities remain in access to health and educa-
tion services and other assets. Moreover, while income
inequality between countries has been reduced, inequal-
ity within countries has risen. There is a growing con-
sensus around the idea that economic growth in itself is
not sufficient to reduce poverty, if it does not benefit
everyone, and does not involve the economic, social and
environmental dimensions of sustainable development.
Central to progress in this area (as with health) is the
development of a rights-based policy that addresses the
needs of disadvantaged and marginalized populations.
Specifically, SDG 10 calls for sustained income growth
for the bottom 40% of the population at a rate higher
than the national average (to be achieved by 2030). This
neglected section of society is also most affected by
NTDs. In Nigeria, for example, more than 60% of
school-aged children revealed inequalities in NTD
prevalence across socioeconomic groups, with the poor
shouldering the greatest burden [132]. In Honduras, be-
ing in a family from higher socio-economic status was
protective against infections by roundworm (Ascaris)
and whipworm (Trichuris) [133]. A study carried out in
Nigeria in 2009 found that the prevalence of ascariasis
among children ranges from 10% when both parents
have at least primary education, to 96% when neither
parent does [134]. A 2015 case-control study using
asset-based analysis undertaken in Ethiopia found not
only that trichiasis cases are more likely to occur in
poorer households but that people living with trichiasis
were less likely to participate in economically productive
activities regardless of visual impairment and other
health problems [135].
Ending NTDs would contribute to reducing these in-
equalities and move closer to achieving the targets of SDG
10. At the same time, SDG 10 also calls for efforts to
empower and promote the social, economic and political
inclusion of all, irrespective of age, sex, disability, race,
ethnicity, origin, religion or economic or other status.
Here, too, NTD programmes and initiatives have an im-
portant part to play in reducing discrimination and the
exclusion and stigmatisation of those living with NTDs.
SDG 11. Make cities inclusive, safe, resilient and
sustainable
Over half of the world’s population now live in urban
areas, and by 2050, it is expected that cities will accom-
modate 6.5 billion people, two-thirds of humanity. The
growth of cities in the developing world, driven in part
by increasing rural to urban migration, has led to the
astonishing development of mega-cities. In 1990, there
were ten mega-cities with 10 million inhabitants or
more. In 2014, there were 28 mega cities, home to 453
million people. Given the strains already apparent in
urban centres, it is clear that sustainable development
cannot be achieved without massively transforming the
way we build and manage urban spaces. To make such
cities safe and sustainable will require access to safe and
affordable housing, which will in turn require upgrading
slum settlements. It will also involve investment in mass
transport systems, the creation of green spaces, and
urban planning and management that is both participa-
tory and inclusive.
Often thought of as a concern solely for remote rural
areas, several NTDs are rooted in the urban environ-
ment. This is partly because of the conditions in which
the urban poor often live and partly because of the affin-
ity for urban areas of certain NTD vectors. The recent
Zika outbreak was a wake-up call to the world, empha-
sizing the necessity to improve the control of vector-
borne diseases, particularly in urban settings, which
remain vulnerable to the transmission of Aedes-borne
diseases. Ae. aegypti, which transmits dengue, Zika,
chikungunya, and yellow fever, thrive in towns and cities
throughout the tropics and sub-tropics. Urban environ-
ments provide ideal larval habitats for this mosquito
including water storage containers, tyres, guttering, and
the plethora of plastic containers discarded as waste. For
diseases, such as leishmaniasis, normally associated with
rural environments, transmission in urban and peri-
urban settings has been reported in Brazil [136], Sudan
(Khartoum) and in Burkina Faso (Ougadougou) and in
Europe [137] leading to an outbreak in a major
European capital (Madrid) [138]. Movement of people
and mosquitoes will also increase the risk of establishing
NTDs in cities previously not affected. The 2013
outbreak of chikungunya in the Caribbean, for example,
led to a seven-fold increase of imported infections to
Spanish cities where the vector was present, thereby
posing a threat of autochthonous transmission [139].
The global incidence of dengue has increased dramat-
ically in recent decades, partly as a result of urban
growth, with the result that roughly half of the world’s
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population is now at risk of infection [140]. Dengue
thrives in urban slums, as indicated by a study based on
community-based surveillance in a slum in Salvador,
Brazil which found 22% of febrile patients with evidence
of dengue infection. The study also suggested that socio-
economic development could potentially mitigate risk
factors for both dengue and non-dengue febrile cases,
and found that residential proximity to a health care fa-
cility was associated with improved case detection [141].
WHO guidelines on preventing or reducing dengue
virus transmission focus on control of the mosquito vec-
tors or interruption of human–vector contact. Activities
to control transmission are directed at removing the
habitats of the immature larval stages in the household
and immediate vicinity, as well as other settings where
human–vector contact occurs (e.g., schools, hospitals
and workplaces), unless there is sound evidence that Ae.
albopictus or other mosquito species are the local vec-
tors of dengue. The provision of reliable piped water,
which prevents people having to store water and creates
potential larval habitats, and efficient domestic waste
management, will lead to fewer larval habitats for Ae.
aegypti and house screening would help reduce the
transmission of Aedes-borne diseases. More emphasis is
being given to community-based vector control strat-
egies that include environmental management [142].
The triatomine bug, a vector for Chagas disease, is an-
other cause of concern as it is associated with poor
housing in urban areas [143]. This despite, previous suc-
cesses in the Southern Cone countries of the Americas
in controlling domestic transmission of Chagas’ diseases
by Triatoma infestans by indoor residual spraying in
urban settings [144, 145]. The control of Chagas’ disease
was based on insecticide spraying to eliminate household
infestation. Because of the focus on domestic transmis-
sion, there has been a tendency to neglect peri-domestic
transmission. Housing improvement, to reduce the num-
ber of sites within houses where vectors can live and
breed (cracks in walls, poor roofing materials, behind
pictures) is also a key part of Chagas disease control,
usually as a part of integrated approaches that combine
spraying, environmental organization and improvement,
health education and community mobilization. As with
so many NTD-related endeavours, community participa-
tion and ownership is crucial [146].
Aedes-borne diseases like dengue, Zika, yellow fever
and chikungunya, and Chagas control initiatives and tar-
gets are closely aligned with the targets set out in SDG
11. The effective prevention of NTDs addresses many of
the social factors that produce unequal health outcomes
among slum residents, in addition to improving sanita-
tion through integrated NTD-WASH interventions.
Environmental health, in particular, recognising the need
to control vectors should be incorporated into future
planning within cities. In Spain, for example, an unusual
urban outbreak of leishmaniasis was attributed to a
conversion of agricultural land to urban parkland, which
may have brought a wild transmission cycle into contact
with people [138], and could have been prevented if
vector borne diseases were considered during the
planning stage.
SDG 12. Ensure sustainable consumption and production
patterns
Achieving economic growth and sustainable develop-
ment will require a change in the way we produce and
consume goods and resources. The efficient manage-
ment of shared natural resources, and sustainable man-
agement of waste disposal, including toxic waste, are
core targets for SDG 12. Halving per capita global food
waste at the retailer and consumer levels, for example,
will create more efficient production and supply chains,
by reducing food losses along production and supply
chains, including post-harvest losses. In future, efforts
will also focus on encouraging industries, businesses and
consumers to recycle and reduce waste.
Of the eleven specific targets for SDG 12, NTD efforts
have a specific bearing on target 4 which calls for the
achievement, by 2020, of environmentally sound man-
agement of chemicals and all wastes throughout their
life cycle, in accordance with agreed international frame-
works, and significantly reduce their release to air, water
and soil in order to minimize their adverse impacts on
human health and the environment. Efforts to end
NTDs align with this target in two important ways, the
first being the responsible production, use and disposal
of pesticides.
Insecticide resistance arising from overreliance on spe-
cific insecticides used in long-lasting insecticidal nets
and in many indoor residual spraying programmes, is a
major cause of concern for NTD and malaria pro-
grammes [147–149]. WHO’s work in this area focuses
on the WHO Pesticide Evaluation Scheme (WHOPES),
a cross-cutting programme based in the Vector Ecology
and Management Unit of the Department of Control of
NTDs, which supports United Nations agencies and
WHO programmes, and assists Member States with vec-
tor control programme implementation [150]. In 1997
WHOPES established the Global Collaboration for the
Development of Pesticides for Public Health (GCDPP)
in response to the need to stimulate the development of
alternative insecticides and application technologies
[150]. GCDPP meetings bring together major stake-
holders in pesticide product development and the sound
management of pesticides, to discuss and strengthen col-
laboration on critical vector control issues.
Efforts to end NTDs also align with target 4 in relation
to waste disposal, focusing on the sustainable production
Bangert et al. Infectious Diseases of Poverty  (2017) 6:73 Page 10 of 20
and recycling of rubber tyres, plastic bottles and other
containers as a part of vector control efforts designed to
halt the global spread of Aedes mosquitos [151, 152]. Ae.
aegypti proliferates in purposely-filled household con-
tainers such as those used for domestic water storage
and for decorative plants, but also in a multiplicity of
rain-filled habitats – including used tyres, discarded food
and beverage containers, blocked gutters and buildings
under construction. Typically, the mosquitoes do not fly
far, most remaining within 100 m of where they emerged
[153]. A study of porcelain and plastic household wastes
serving as larval habitats of vectors of Aedes-borne dis-
eases in rural and urban areas around Kolkata, India,
found that porcelain and plastic wastes were more pro-
ductive (i.e., more larvae developed in them) in urban
areas compared to rural areas. The risk of dengue epi-
demics was expected to increase if waste generation con-
tinued without appropriate measures being applied to
limit the addition of such waste to the environment. The
study suggested that increase use of biodegradable con-
tainers might reduce the problem of waste and mosquito
production [154].
SDG 13. Take urgent action to combat climate change
and its impacts
SDG 13 calls for urgent collective action on climate
change and its impacts, and focuses on five targets, three
of which have particular relevance for NTD pro-
grammes. These are: target one, on strengthening the re-
silience and adaptive capacity to climate-related hazards
and natural disasters in all countries; target three on
improving education, awareness-raising and human and
institutional capacity on climate change mitigation,
adaptation, impact reduction and early warning; and tar-
get five on promoting mechanisms for raising capacity
for effective climate change-related planning and man-
agement in least developed countries and small island
developing States, including focusing on women, youth
and local and marginalized communities.
Strengthening the resilience and adaptive capacity to
climate-related hazards depends in part on an under-
standing of the links between climate change and the
epidemiology of certain NTDs. The fact that climate
change is happening and is likely to expand the geo-
graphical distribution of several vector borne infections
is well established [155]. The spread of malaria is, of
course, a major concern, but in the context of the
NTDs, attention is focused on the spread of dengue, for
which there is increasing evidence of an association be-
tween epidemics and temperature, rainfall and relative
humidity [156]. In response to drought, for example,
water collection frequently occurs resulting in new
breeding habitats for vectors [157]. This is further exem-
plified by the northward spread of the Chagas disease
[158] and leishmaniasis [159] vectors in the USA and
Europe, respectively. Similarly, mean water temperatures
are expected to increase in the south of Europe which
will enhance the capacity of snails to overwinter, leading
to more schistosomiasis outbreaks as seen in Corsica
(France) [26].
The effectiveness of future responses to these diseases
requires an understanding of the changing dynamics of
the pathogen, host (human and/or reservoir animal) and
vector as well as the environmental dynamics which re-
sult from climate change. Each species responds to
environmental changes differently, and in order to pre-
dict the movement of disease through ecosystems, we
have to rely on expertise from the fields of veterinary,
medical, and public health in line with the One Health
strategy [160]. Modelling and surveillance of human and
vector behaviour can also help us better understand the
environmental and climatic factors driving diseases and
help counteract potential impacts [161, 162].
Target three, focuses on awareness and education;
NTD programmes raise awareness and increase know-
ledge among populations, public health practitioners,
and policy makers about vector-transmitted infections
and their relationship to disease which serves as the
basis for prevention strategies such as personal protec-
tion, improved hygiene and reducing exposure to vectors
or intermediate hosts (snails and schistosomiasis/Cyclops
and Guinea worm).
SDG 14. Conserve and sustainably use the oceans, seas
and marine resources
Over three billion people depend on marine and coastal
biodiversity for their livelihoods. However, decades of
overfishing and pollution of the oceans has brought mar-
ine environments and fish stocks to the point of col-
lapse. It estimated that 30% of the world’s fish stocks are
over-exploited, well above a level to produce sustainable
yields. Marine pollution, an overwhelming majority of
which comes from land-based sources, is reaching
alarming levels, with an average of 13 000 pieces of plas-
tic litter to be found on every square kilometre of ocean.
Oceans are also changing as a result of greenhouse gas
emissions driven by industrialisation as they absorb
about 30% of the carbon dioxide produced by humans
and hence are becoming increasingly acid. There has
been a 26% rise in ocean acidification since the begin-
ning of the industrial revolution. Similarly important
and at-risk are fresh-water bodies, which provide the
equivalent of all dietary animal protein for 158 million
people, particularly in poor and undernourished popula-
tions [163]. The Sustainable Development Goals create a
framework to sustainably manage and protect marine
and coastal ecosystems from land-based pollution, as
well as address the impacts of ocean acidification.
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Enhancing conservation and the sustainable use of
ocean-based resources through international law will
also help mitigate some of the challenges facing our
oceans.
In addition to water pollution and overfishing, fresh
water fish populations can be affected by diseases. Fish-
borne zoonotic trematodes (FZT) are important emer-
ging and re-emerging pathogens causing liver and intes-
tinal fluke diseases in humans [164]. It is estimated that
750 million people worldwide are at risk of infection
[165] with more than 46 million people infected [166].
Parasitic infection also impacts fish, resulting in reduced
fitness, which impacts on the food web and therefore
also on the entire marine ecosystem [167]. Trematode
parasite larvae in water bodies, which use snails as their
intermediate host, infect and mature within fish or
crustacea. Humans are then infected when they eat these
fish either raw, inadequately cooked, dried, salted or
pickled, and re-introduce these parasites into the water
via faeces [168].
As such, NTD interventions will have an impact on
several trematode diseases. Where human faeces are dis-
posed of directly into water (sometimes to feed fish
stocks), treatment of infected individuals can help break
the cycle of transmission and improve the health of fish
populations and safety of small-scale fish production
[169, 170]. Secondly, education and provision of Water
Sanitation and Hygiene (WASH) coverage, part of the
joint WASH-NTD strategy, would prevent open
defecation and reduce infections [101].
Even though the impact of FZT on aquatic ecosystems
is limited in comparison to pollution and overfishing,
addressing the burden of NTDs will also contribute to
achieving some of SDG14 targets.
SDG 15. Sustainably manage forests, combat
desertification, halt and reverse land degradation, halt
biodiversity loss
In a list of extremely broad and ambitious goals, SDG 15
is one of the broadest and most ambitious, addressing
the colossal challenges such as land degradation and bio-
diversity loss. The specific references to forest manage-
ment, and the issue of desertification offers some scope
for focus. The impacts of NTDs, and NTD responses on
these targets is particular rather than general, but they
are nevertheless significant, notably with regard to redu-
cing the impact of invasive parasites and pests on eco-
systems [171].
One of the key drivers of the NTD epidemic in recent
years is the expansion of industrial-scale plantations –
monocultures- that are actively managed for the com-
mercial production of commodities from lumber to
latex. The unprecedented expansion in global trade in
recent decades [172] has encouraged the expansion of
rubber plantations in South East Asia which provide
ideal habitats for the mosquito vectors of malaria, den-
gue, and chikungunya [171]. Similarly, illegal logging
and other plantation cultures including teak, palm oil,
pine forest and eucalyptus have created ideal environ-
ment for transmission of vector borne infections [173].
Often tended by migrant workers, frequently non im-
mune groups with no previous exposure to these infec-
tions, they also act as repositories for pathogens brought
in from outside, most worryingly artemisinin-resistant
malaria parasites [174]. The close proximity of rubber
plantations to natural forest also increases the threat
from zoonoses, where new vector-borne pathogens spill
over from wild animals into humans [175]. Previous re-
introduction of zoonotic disease in ecosystems has led
to loss of wildlife and even the risk of extinction of some
species, such as wild dogs in Africa due to rabies [176].
There is, therefore, a need to scale up surveillance
of vectors and diseases as well as access to health
care for plantation workers. Achieving this will re-
quire an inter-sectoral approach with strong collabor-
ation between the health sector, the forest industries
and local communities. By addressing vector-borne
NTDs, particularly in migrant workers, the introduc-
tion of alien vectors and arboviruses into these
ecosystems can be prevented [177].
Another area of concern for NTD programmes that
has direct relevance for SDG 15 is the degradation of
land and soil as a result of unsafe sanitation arrange-
ments and practices such as open defecation. Such deg-
radation is a significant driver of ascariasis, trichuriasis
and hookworm disease, all of which are transmitted via
soil and other media that are contaminated with excreta
containing infective eggs or larvae. Transmission typic-
ally takes place near the home, or in a communal area
with inadequate sanitation facilities and occurs when in-
fective eggs are ingested, and in the case of hookworm
disease, also when infective larvae penetrate the skin
[178]. Transmission does not occur from person-to-per-
son or from contact with fresh faeces because it takes
time for the parasite to develop. For this reason these
nematode infections are considered to be entirely at-
tributable to the environment, and occur because of a
lack of excreta management and inadequate hygiene
practices [179].
NTD programme responses have focused on deworm-
ing which has been shown to reduce environmental con-
tamination with soil transmitted helminth eggs [180].
However, rapid re-infection occurs in areas where
hygiene, access to clean water and sanitation are inad-
equate [181]. Therefore, WASH interventions are a vital
a component of any response. The community-led total
sanitation approach that is a core focus of UNICEF’s
sanitation work has been successful in several countries,
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notable among them, Ethiopia. A key aspect of the
approach is effectively communicating to communities
the risks of open defecation. However, behaviour change
is not possible without the latrines needed to accommo-
date it. UNICEF works in conjunction with the
Ethiopian government to engage the private sector by
marketing sanitation throughout the country. The push
to upgrade the country’s toilets dates back to 2003 in the
Southern Nations Nationalities and Peoples Region
(SNNPR) of Ethiopia, where it became compulsory for
each household to have and use a latrine. Today, the
SNNPR reports 75% access to sanitation, the highest of
any region in Ethiopia. In the country, as a whole, access
to safe sanitation has risen from 7% in 2000 to 60%
today [182].
SDG 16. Promote just, peaceful and inclusive societies
Ensuring peace, stability, human rights and effective
governance based on the rule of law is a prerequisite for
sustainable development. SDG 16 aims to significantly
reduce all forms of violence, and work with governments
and communities to find lasting solutions to conflict and
insecurity. Strengthening the rule of law and promot-
ing human rights is key to this process, as is reducing
the flow of illicit arms and strengthening the partici-
pation of developing countries in the institutions of
global governance.
Advocacy for the elimination of NTDs can also pro-
mote peace. Importantly, the Guinea worm cease fire ne-
gotiated by President Jimmy Carter in South Sudan not
only enabled progress in Guinea worm eradication to be
maintained, but appeased warring factions, albeit for a
short time [183]. Such peace deals will become more
important as countries apply for the certification of the
absence of Guinea worm transmission in the remaining
countries yet to be certified. However, a major challenge
will be to achieve access to areas where there are secur-
ity problems, such as in Kidal, Mali and West Darfur
[184]. Similarly, the effects of conflict on leishmaniasis
are well documented, where the current refugee crisis
has led to unprecedented number of new cases of the
cutaneous form of the disease [185–187].
Interventions against NTDs are unlikely to be priori-
tised in these situations where humanitarian needs are
the first concern of agencies involved in the many
geopolitical crises. This is notably the case in regard to
reducing the fear that drives institutional discrimination
against NTD-related disability. People affected by NTDs
are frequently the target of social stigmatization. Leprosy
is an obvious example [188], and has been a major focus
of stigma studies in the past. However, there are many
other NTDs for which stigma is an important
consideration, including onchocerciasis [189], lymphatic
filariasis [115], Buruli ulcer [190], leishmaniasis [191],
schistosomiasis [192] and Chagas disease [193]. The
psycho-social aspects of stigmatisation associated with
disfiguring NTDs is well documented, but stigma is also
an important social determinant of the effectiveness of
disease control because of its impact on help-seeking
and treatment adherence. Furthermore, it has been
shown that stigma influences political commitment to
NTD control [56, 194].
Efforts to control NTDs include initiatives to encour-
age social inclusion and may sensitize local populations
to risks, reducing fear and stigma that are manifested
also by local institutions, in spite of non-discrimination
laws. A good example of this was the launching of a
powerful and broad-based advertising campaign to
change the public image of leprosy by the Sri Lankan
Ministry of Health, assisted by international support, in
1990. By portraying leprosy as just another treatable dis-
ease, the campaign hoped to encourage people with
suspicious lesions to come forward for early diagnosis
and cure free of charge. The campaign strongly reduced
the stigma attached to leprosy, enabling a shift from re-
actions of fear and loathing to understanding and com-
passion, and for those living with disease, a shift from
despair to hope for a cure. As a result of this and other
interventions, the public health problem of leprosy has
been eliminated in Sri Lanka since 1996.
Research suggests that the most effective approach
to this issue may be joint interventions rather than
initiatives focused on one disease at a time. A sys-
tematic review of 52 articles which provided evi-
dence on stigma found that commonalities in the
reasons for and nature of the stigma applying to all
of the diseases considered suggested that a joint ap-
proach to reduce stigmatization might be feasible.
The same study suggested that lessons from leprosy
and other stigmatizing health conditions can be used
to plan such joint approaches [194].
SDG 17 Revitalize the global partnership for sustainable
development
As noted at the outset, the SDGs can only be real-
ized with a strong commitment to global partnership
and cooperation. A successful sustainable develop-
ment agenda requires partnerships between govern-
ments, the private sector and civil society. These
inclusive partnerships built upon principles and
values, a shared vision, and shared goals that place
people and the planet at the centre, are needed at
the global, regional, national and local level. SDG 17
calls for urgent action to mobilize, redirect and un-
lock the transformative power of trillions of dollars
of private resources to deliver on sustainable devel-
opment objectives.
Bangert et al. Infectious Diseases of Poverty  (2017) 6:73 Page 13 of 20
The NTD agenda has been characterised by strong
global partnerships from the beginning. Under the guid-
ance or leadership of WHO, these have proven key to
tackling the diseases effectively and have helped to mo-
bilise resources [2]. Examples abound [195], dating back
to the early 1990s with the exception of International
Federation of Anti-Leprosy Associations (ILEP) which
was founded in 1966. Relatively recent additions include
the NTD NGDO Network which was established in
October 2009, and provides a global forum for non-
governmental development organizations (NGDOs) and
a wide range of other partners, and Uniting to Combat
NTDs, a collective of invested, interested and dedicated
partners, working to fulfil the London Declaration on
NTDs (2012).
Such partnerships have brought together a broad
range of actors, including governments and other
stakeholders in endemic countries, international
agencies, pharmaceutical companies, international
non-governmental organizations, academia, civil soci-
ety and UN agencies [4]. Many of these partners
have come together as a result of more integrated
approaches to prevention and control, which have
coalesced around the WHO’s Global Plan to combat
neglected tropical diseases, 2008 – 2015, and the
Roadmap for Implementation.
Inspired by the 2020 Roadmap, a group of high-profile
stakeholders including bilateral donors, the World Bank,
the Bill and Melinda Gates Foundation, and several
pharmaceutical companies, came together under the
London Declaration of 2012, pledging to provide the
resources necessary for implementation. A cornerstone
of the London Declaration is the contribution of do-
nated drugs from pharmaceutical companies. Over 5.5
billion tablets have been donated providing 3.5 billion
treatments since the launch of the London Declaration
in 2012. In 2014, 1.45 billion treatments were made
available to endemic countries, representing a 36% in-
crease since 2011.
Public–private partnerships (PPPs) in NTDs have
been key [196], bringing together NGOs, who, work-
ing in partnership with governments, have played a
critical role in advocacy, resource mobilisation and
implementation. Their technical assistance has helped
governments to develop community-based methods of
drug distribution, ensuring that ‘essential drugs’ reach
those most in need [196]. PPPs have also been crucial
in driving costs down allowing NTDs to be treated in
an extremely cost-effective way. It has been estimated
that treating one person for all seven major NTDs
costs approximately 50 cents per year, which can be
even lower in Asian countries [197–199].
In many ways ending NTDs exemplify the poten-
tial of public private partnership and domestic
financing. The global effort to control and eliminate
NTDs is one of the largest public health initiatives
ever. In 2015 alone, pharmaceutical companies do-
nated an estimated 2.4 billion tablets, enough for 1.5
billion treatments to prevent and treat NTDs.
Conclusions
NTDs and the responses developed for their control
or elimination, are woven into the fabric of the 2030
Agenda. In this scoping review we have shown how
NTD programmes and initiatives have implications
for multiple goals (see Table 1). This is true, for ex-
ample, of preventive chemotherapy, which, as dem-
onstrated here, has a bearing on poverty, hunger,
education, employment and equality, to name the
SDGs’ most directly impacted. The provision of
clean water and sanitation as part of integrated
WASH responses against NTDs that thrive where
these are inadequate, have impact beyond the inter-
ruption of disease transmission, and can elevate the
quality of life of those affected. We have shown how
community-led distribution of medicines to more
than 1 billion at-risk people each year can empower
women, develop infrastructure and combat discrim-
ination against disability. Interventions to curb
mosquito-borne NTDs contribute to the goals of
urban sustainability and resilience to climate change,
while the safe use of insecticides supports the goal
of sustainable ecosystems. Although indirectly, inter-
ventions to control water- and animal-related NTDs
can facilitate the goals of small-scale fishing and sus-
tainable hydroelectricity and biofuels. It is important
to note, however, that not all NTD programs will, or
can, engage on all SDGs at all levels. Some of the
examples cited will occur in only a small number of
communities in a selection of countries.
To measure the progress of the NTD target in the
context of the SDG goal, the WHO will be tracking
and reporting the number of people requiring inter-
ventions against neglected tropical diseases. In
addition, the WHO will monitor NTDs in the con-
text of a few targeted SDGs. Most notably, within
the health target, the WHO will use NTD indicators
to monitor equity towards the goal of Universal
Health Coverage. Beyond the health goal, but critical
to the NTD agenda, NTDs will be used to track
progress on the “Provision of Clean Water”, “No
Poverty”, “Zero Hunger”, “Quality Education” and
“Sustainable Cities and Communities” targets.
Remarkable progress has already been made to-
wards achieving the end of the epidemic of NTDs
even without the financial support seen for other
disease interventions. Importantly, the strong
political will to address the suffering of the most
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Table 1 The sustainable development goals, the linkage between SDGs and NTDs and the NTDs referenced
SDG NTD-SDG linkage NTDs referenced
1 - End poverty in all its
forms everywhere.
NTDs and the medical poverty trap: Debilitating
diseases cause significant economic burden to affected
individuals, households and communities. Free of
charge and community directed interventions in
addition to preventive care can reduce this burden.
Dengue, Chikungunya, Lymphatic filariasis,
onchocerciasis Leishmaniasis, Buruli Ulcer,
Cysticercosis. Trachoma, Schistosomiasis
2 - End hunger, achieve food security
and improved nutrition and promote
sustainable agriculture.
Worm infections reduces nutrient uptake in human and
animal hosts while infections from other NTDs reduces
ability to work. Treating the affected can improve food
security and ensure healthy livestock.
STH, schistosomiasis, Chagas, Dracunaliasis,
trachoma, lymphatic filariasis, onchocerciasis,
HAT, dracunculiasis
3 - Ensure healthy lives and promote
well-being for all
NTDs affect all aspects of healthy lives. The promotion
of Universal Health Coverage as part of NTD
interventions ensures well-being beyond the NTDs.
All NTDs
4 - Ensure inclusive and equitable quality
education and promote lifelong learning
opportunities for all.
NTDs can cause stigma and reduce school attendance,
performance and cognitive ability. School based
programs, including deworming and health education,
ensure children can attend school.
Lymphatic filariasis, cutaneous leishmaniasis,
STH, Schistosomiasis,
5 - Achieve gender equality and
empower all women and girls
NTDs disproportionally impact the health of girls and
women. Community directed distribution programs and
women’s groups as part of drug distribution programs
can empower women.
STH, Zika, Chagas, Schistosomiasis,
onchocerciasis, lymphatic filariasis
6 - Ensure access to water and
sanitation for all.
Water and sanitation play an important role in the
lifecycle of most NTDs. The joint WASH-NTD strategy
aims to improve access to water and sanitation for the
most disadvantaged populations.
STH, Dracunculiasis, Trachoma, Schistosomiasis,
Onchocerciasis, Lymphatic filariasis, Dengue,
Chikungunya
7 - Ensure access to affordable, reliable,
sustainable and modern energy for all
Construction of dams can serve as breeding sites while
biogas material used can be infectious. Impact of dams
on water tables can change vector ecology. Vector
control and the disinfection of biogas material can
leverage the proliferation of rural sustainable energy
projects.
Schistosomiasis, Onchocerciasis, Lymphatic
filariasis
8 - Promote inclusive and sustainable
economic growth, employment
and decent work for all
NTD infections are a large burden to health care system
and reduce economic productivity of the workforce.
Deworming and sustained vector control ensures
limited impact on health care system and a healthy
workforce.
STH, lymphatic filiarisis, rabies, dengue,
hookworm, schistosomiasis,
9 - Build resilient infrastructure, promote
sustainable industrialization and foster
innovation
Interventions to the most neglected populations
requires development and investment in supply chains
including transport and storage infrastructure as well as
clinics for distribution of donated medicines.
STH, Dracunculiasis, Trachoma, onchocerciasis,
Schistosomiasis, Lymphatic filariasis
10 - Reduce inequality within
and among countries.
Inequalities in disease prevalence across socioeconomic
groups is a hallmark of NTDs. Interventions aimed at the
most disadvantaged and marginalized populations aims
to reduce this inequality.
All NTDs
11 - Make cities inclusive, safe, resilient
and sustainable
Mosquito and other disease vectors have adapted and
proliferated in urban environments. Actively removing
breeding sites through community based interventions
ensures cities are resilient to this threat.
Leishmaniasis, Chagas, Dengue, Chikungunya,
Zika, Yellow Fever
12- Ensure sustainable consumption
and production patterns
Chemicals are frequently used to combat nuisance or
disease vector mosquitos. The sustainable use and
management of chemicals is ensured through
continued pesticide safety and efficacy evaluation.
Dengue, Chikungunya, Zika, Yellow Fever
13 - Take urgent action to combat
climate change and its impacts
Vector borne disease epidemics increase with changes
in temperature, rainfall and relative humidity. A better
understanding of the effect of climate change can be
gained through modelling and surveillance of the
interaction between NTDs and climate.
Dengue, Chikungunya, Zika, Yellow Fever,
schistosomiasis, lymphatic filariasis
14 - Conserve and sustainably use the
oceans, seas and marine resources
Clean water bodies are important to maintain food
security and good sanitation. NTD interventions can
address contaminated water through treatment
programs and by providing educational service to
affected communities.
Trematodes
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marginalized populations has meant that programs
were able to have an impact even during financial
crisis and conflicts. The challenges presented by
NTDs require the multi-sectoral responses encour-
aged by the 2030 Agenda. This should remind the
NTD community to think differently about the im-
pact their interventions have, and be proactive in
working across sectors and disciplines to ensure pro-
gress towards sustainable development.
Additional file
Additional file 1: Multilingual abstracts in the five official working
languages of the United Nations. (PDF 474 kb)
Abbreviations
MDA: Mass drug administration; MDGs: Millennium development goals;
NTDs: Neglected tropical diseases; SDGs: Sustainable development goals;
STH: Soil-transmitted helminths; WASH: Water, sanitation and hygiene
Acknowledgements
We thank the disease specific coordinators at WHO/NTDs for discussions,
Gary J Humphries for helping develop the text and Evan Drake for critical
feedback.
Funding
DHM receives support from GSK and from the Department for International
Development supported COUNTDOWN Implementation Research project to
the Liverpool School of Tropical Medicine.
Availability of data and materials
Not applicable to this article as no datasets were generated or analysed
during the current study.
Authors’ contributions
MB, DHM, SL, CF and DE collected references, wrote and reviewed the
manuscripts. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Not applicable.
Declarations
The authors alone are responsible for the views expressed in this publication
and they do not necessarily represent the decisions or policies of the World
Health Organization.
Author details
1Department of Control of Neglected Tropical Diseases, World Health
Organization, 20 Avenue Appia, 1211 Geneva, Switzerland. 2Department of
Parasitology, Liverpool School of Tropical Medicine, Liverpool, UK.
3Department of Biosciences, Durham University, Durham, UK.
Received: 26 December 2016 Accepted: 16 March 2017
References
1. Boerma JT, World Health Organization. Health in 2015: from MDGS,
millennium development goals, to SDGS, sustainable development
goals. 2015.
2. World Health Organization. Working to overcome the global impact of
neglected tropical diseases: first WHO report on neglected tropical diseases.
Geneva: Department of Reproductive health and Research, World Health
Organization; 2010.
3. Fitzpatrick C, Engels D. Leaving no one behind: a neglected tropical disease
indicator and tracers for the Sustainable Development Goals. Int Health.
2016;8 Suppl 1:i15–8.
4. Molyneux DH. The “Neglected Tropical Diseases”: now a brand identity;
responsibilities, context and promise. Parasit Vectors. 2012;5:23.
5. Engels D. Neglected tropical diseases in the Sustainable Development
Goals. Lancet. 2016;387:223–4.
6. Molyneux DH, Savioli L, Engels D. Neglected tropical diseases: progress
towards addressing the chronic pandemic. Lancet. 2016. doi:10.1016/
S0140-6736(16)30171-4.
7. Fitzpatrick C, Bangert M, Engels D. Sustainable Development Goals: diseases
that neglect no goals. Nature. 2016;535:493.
8. Smith J, Taylor EM. What Is Next for NTDs in the Era of the Sustainable
Development Goals? PLoS Negl Trop Dis. 2016;10:e0004719.
9. Huy R, Wichmann O, Beatty M, Ngan C, Duong S, Margolis HS, et al.
Cost of dengue and other febrile illnesses to households in rural
Cambodia: a prospective community-based case-control study. BMC
Public Health. 2009;9:155.
10. Anoopa Sharma D, Bern C, Varghese B, Chowdhury R, Haque R, Ali M, et al.
The economic impact of visceral leishmaniasis on households in
Bangladesh. Trop Med Int Health TM IH. 2006;11:757–64.
11. Uranw S, Meheus F, Baltussen R, Rijal S, Boelaert M. The household costs of
visceral leishmaniasis care in south-eastern Nepal. PLoS Negl Trop Dis.
2013;7:e2062.
12. Perera M, Whitehead M, Molyneux D, Weerasooriya M, Gunatilleke G.
Neglected patients with a neglected disease? A qualitative study of
lymphatic filariasis. PLoS Negl Trop Dis. 2007;1:e128.
13. Boelaert M, Meheus F, Robays J, Lutumba P. Socio–economic aspects of
neglected diseases: sleeping sickness and visceral leishmaniasis. Ann Trop
Med Parasitol. 2010;104:535–42.
Table 1 The sustainable development goals, the linkage between SDGs and NTDs and the NTDs referenced (Continued)
15 - Sustainably manage forests, combat
desertification, halt and reverse land
degradation, halt biodiversity loss
Deforestation leads to the proliferation of vector borne
disease affecting people who work or live at interface
with forest. Active vector control and providing
educational service to affected communities can
mitigate the impact of disease vector proliferation.
Dengue, Chikungunya, Zika, Yellow Fever,
cutaneous leishmaniasis, loiasis,
16 - Promote just, peaceful and inclusive
societies
NTD disease epidemics frequently occur during times of
war and crisis. Advocating for interventions to affected
populations in times of crisis can be used as a tool to
promote peace.
Dracunculiasis, leishmaniasis
17 - Revitalize the global partnership
for sustainable development
Public–private partnerships for NTD interventions have
been key and effective. Experience gained from working
with these partnerships can be used to build on
partnerships for other SDG themes.
All NTDs
Bangert et al. Infectious Diseases of Poverty  (2017) 6:73 Page 16 of 20
14. Soumahoro M-K, Boelle P-Y, Gaüzere B-A, Atsou K, Pelat C, Lambert B, et al.
The chikungunya epidemic on La Réunion Island in 2005–2006: a cost-of-
illness study. PLoS Negl Trop Dis. 2011;5:e1197.
15. Xu K, Evans DB, Kawabata K, Zeramdini R, Klavus J, Murray CJ. Household
catastrophic health expenditure: a multicountry analysis. Lancet.
2003;362:111–7.
16. Chukwu JN, Meka AO, Nwafor CC, Oshi DC, Madichie NO, Ekeke N, et al.
Financial burden of health care for Buruli ulcer patients in Nigeria: the
patients’ perspective. Int Health. 2016;9:36–43.
17. Nkwengulila G. The financial costs associated with porcine cysticercosis and
epilepsy in Iringa rural district. Health (N Y). 2014;06:2959–65.
18. World Health Organization. Health statistics and information systems.
Estimates for 2000–2012. http://www.who.int/healthinfo/global_burden_
disease/estimates/en. Accessed 11 Mar 2016.
19. Hotez PJ. NTDs V.2.0: “blue marble health”–neglected tropical disease
control and elimination in a shifting health policy landscape. PLoS Negl
Trop Dis. 2013;7:e2570.
20. Hotez PJ. Fighting neglected tropical diseases in the southern United States.
BMJ. 2012;345:e6112.
21. Taylor HR, Fox SS, Xie J, Dunn RA, Arnold A-LMR, Keeffe JE. The prevalence
of trachoma in Australia: the National Indigenous Eye Health Survey. Med J
Aust. 2010;192:248–53.
22. Ready PD. Leishmaniasis emergence in Europe. Euro Surveill Bull Eur Sur Mal
Transm Eur Commun Dis Bull. 2010;15:19505.
23. Lourenço J, Recker M. The 2012 Madeira dengue outbreak: epidemiological
determinants and future epidemic potential. PLoS Negl Trop Dis.
2014;8:e3083.
24. Succo T, Leparc-Goffart I, Ferré J-B, Roiz D, Broche B, Maquart M, et al.
Autochthonous dengue outbreak in Nîmes, South of France, July to
September 2015. Eurosurveillance. 2016;21: doi:10.2807/1560-7917.ES.
2016.21.21.30240.
25. Viennet E, Ritchie SA, Williams CR, Faddy HM, Harley D. Public health
responses to and challenges for the control of dengue transmission in
high-income countries: four case studies. PLoS Negl Trop Dis.
2016;10:e0004943.
26. Boissier J, Grech-Angelini S, Webster BL, Allienne J-F, Huyse T, Mas-Coma S,
et al. Outbreak of urogenital schistosomiasis in Corsica (France): an
epidemiological case study. Lancet Infect Dis. 2016;16:971–9.
27. Litt E, Baker MC, Molyneux D. Neglected tropical diseases and mental
health: a perspective on comorbidity. Trends Parasitol. 2012;28:195–201.
28. World Health Organization. Investing to overcome the global impact of
neglected tropical diseases: third WHO report on neglected tropical
diseases. Geneva: World Health Organization; 2015.
29. Crompton DWT, Nesheim MC. Nutritional impact of intestinal helminthiasis
during the human life cycle. Annu Rev Nutr. 2002;22:35–59.
30. Hall A, Hewitt G, Tuffrey V, de Silva N. A review and meta-analysis of the
impact of intestinal worms on child growth and nutrition. Matern Child
Nutr. 2008;4 Suppl 1:118–236.
31. Hotez PJ, Molyneux DH. Tropical anemia: one of Africa’s great killers and a
rationale for linking malaria and neglected tropical disease control to
achieve a common goal. PLoS Negl Trop Dis. 2008;2:e270.
32. Charlier J, van der Voort M, Kenyon F, Skuce P, Vercruysse J. Chasing
helminths and their economic impact on farmed ruminants. Trends
Parasitol. 2014;30:361–7.
33. Perri AF, Mejía ME, Licoff N, Lazaro L, Miglierina M, Ornstein A, et al.
Gastrointestinal parasites presence during the peripartum decreases
total milk production in grazing dairy Holstein cows. Vet Parasitol.
2011;178:311–8.
34. Achukwi MD, Tanya VN, Hill EW, Bradley DG, Meghen C, Sauveroche B, et al.
Susceptibility of the Namchi and Kapsiki cattle of Cameroon to
trypanosome infection. Trop Anim Health Prod. 1997;29:219–26.
35. de Noya BA, Díaz-Bello Z, Colmenares C, Ruiz-Guevara R, Mauriello L,
Muñoz-Calderón A, et al. Update on oral Chagas disease outbreaks in
Venezuela: epidemiological, clinical and diagnostic approaches. Mem Inst
Oswaldo Cruz. 2015;110:377–86.
36. Biswas G, Sankara DP, Agua-Agum J, Maiga A. Dracunculiasis (guinea worm
disease): eradication without a drug or a vaccine. Philos Trans R Soc B Biol
Sci. 2013;368:20120146.
37. Palmer SL, Winskell K, Patterson AE, Boubacar K, Ibrahim F, Namata I, et al.
“A living death”: a qualitative assessment of quality of life among women
with trichiasis in rural Niger. Int Health. 2014;6:291–7.
38. Frick KD, Melia BM, Buhrmann RR, West SK. Trichiasis and disability in a
trachoma-endemic area of Tanzania. Arch Ophthalmol Chic Ill 1960.
2001;119:1839–44.
39. Turner HC, Truscott JE, Hollingsworth TD, Bettis AA, Brooker SJ, Anderson
RM. Cost and cost-effectiveness of soil-transmitted helminth treatment
programmes: systematic review and research needs. Parasit Vectors.
2015;8:355.
40. Campbell SJ, Savage GB, Gray DJ, Atkinson J-AM, Soares Magalhães RJ, Nery
SV, et al. Water, sanitation, and hygiene (WASH): a critical component for
sustainable soil-transmitted helminth and schistosomiasis control. PLoS Negl
Trop Dis. 2014;8:e2651.
41. Ndeffo Mbah ML, Kjetland EF, Atkins KE, Poolman EM, Orenstein EW, Meyers
LA, et al. Cost-effectiveness of a community-based intervention for reducing
the transmission of Schistosoma haematobium and HIV in Africa. Proc Natl
Acad Sci. 2013;110:7952–7.
42. Guanghan H, Dandan L, Shaoji Z, Xiaojun Z, Zenghua K, Guojun C. The role
of health education for schistosomiasis control in heavy endemic area of
Poyang Lake region, People’s Republic of China. Southeast Asian J Trop
Med Public Health. 2000;31:467–72.
43. Doenhoff MJ, Hagan P, Cioli D, Southgate V, Pica-Mattoccia L, Botros S, et al.
Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and
current research needs. Parasitology. 2009;136:1825.
44. Secor EW. Water-based interventions for schistosomiasis control. Pathog
Glob Health. 2014;108:246–54.
45. Croke K, Hicks JH, Hsu E, Kremer M, Miguel E. Does Mass Deworming Affect
Child Nutrition? Meta-analysis, Cost-Effectiveness, and Statistical Power. Natl
Bur Econ Res Work Pap Ser. 2016;22382. doi:10.3386/w22382.
46. World Health Organization. Monitoring health for the SDGs: sustainable
development goals. Geneva: World Health Organization; 2016.
47. World Health Organization. Accelerating work to overcome the global
impact of neglected tropical diseases: a roadmap for implementation. 2012.
48. World Health Organization. Sixty-sixth world health assembly: neglected
tropical diseases. 2013.
49. Summers LH. Economists’ declaration on universal health coverage. Lancet.
2015;386:2112–3.
50. Hotez PJ, Fenwick A, Savioli L, Molyneux DH. Rescuing the bottom billion
through control of neglected tropical diseases. Lancet Lond Engl.
2009;373:1570–5.
51. Miguel E, Kremer M. Worms: identifying impacts on education and health in
the presence of treatment externalities. Econometrica. 2004;72:159–217.
52. Sakti H, Nokes C, Hertanto WS, Hendratno S, Hall A, Bundy DA, et al.
Evidence for an association between hookworm infection and cognitive
function in Indonesian school children. Trop Med Int Health TM IH.
1999;4:322–34.
53. Bundy DAP, Kremer M, Bleakley H, Jukes MCH, Miguel E. Deworming and
development: asking the right questions, asking the questions right. PLoS
Negl Trop Dis. 2009;3:e362.
54. Ahmed A, Al-Mekhlafi HM, Azam MN, Ithoi I, Al-Adhroey AH, Abdulsalam
AM, et al. Soil-transmitted helminthiasis: a critical but neglected factor
influencing school participation of Aboriginal children in rural Malaysia.
Parasitology. 2012;139:802–8.
55. Liu C, Luo R, Yi H, Zhang L, Li S, Bai Y, et al. Soil-transmitted helminths in
southwestern China: a cross-sectional study of links to cognitive ability,
nutrition, and school performance among children. PLoS Negl Trop Dis.
2015;9:e0003877.
56. Weiss MG. Stigma and the social burden of neglected tropical diseases.
PLoS Negl Trop Dis. 2008;2:e237.
57. World Health Organization. Preventive chemotherapy in human
helminthiasis: coordinated use of anthelminthic drugs in control
interventions ; a manual for health professionals and programme managers.
Geneva: World Health Organization; 2006.
58. Nokes C, Grantham-McGregor SM, Sawyer AW, Cooper ES, Bundy DA.
Parasitic helminth infection and cognitive function in school children. Proc
Biol Sci. 1992;247:77–81.
59. Grigorenko EL, Sternberg RJ, Jukes M, Alcock K, Lambo J, Ngorosho D, et al.
Effects of antiparasitic treatment on dynamically and statically tested
cognitive skills over time. J Appl Dev Psychol. 2006;27:499–526.
60. Jukes MCH, Drake LJ, Bundy DAP. School health, nutrition and education for
all: levelling the playing field. Wallingford, UK. Cambridge: CABI Pub; 2008.
61. Baird S, Kremer M, Hicks J, Miguel E. Worms at work: long-Run impacts of
child health gains. 2011.
Bangert et al. Infectious Diseases of Poverty  (2017) 6:73 Page 17 of 20
62. Hicks JH, Kremer M, Miguel E. The case for mass treatment of intestinal
helminths in endemic areas. PLoS Negl Trop Dis. 2015;9:e0004214.
63. Taylor-Robinson DC, Maayan N, Soares-Weiser K, Donegan S, Garner P.
Deworming drugs for soil-transmitted intestinal worms in children: effects
on nutritional indicators, haemoglobin, and school performance. In: The
Cochrane Collaboration, editor. Cochrane Database of Systematic Reviews.
Chichester: Wiley; 2015. http://doi.wiley.com/10.1002/14651858.CD000371.
pub6. Accessed 28 Oct 2016.
64. de Silva N, Ahmed B-N, Casapia M, de Silva HJ, Gyapong J, Malecela M, et al.
Cochrane reviews on deworming and the right to a healthy, worm-free life.
PLoS Negl Trop Dis. 2015;9:e0004203.
65. Montresor A, Addiss D, Albonico M, Ali SM, Ault SK, Gabrielli A-F, et al.
Methodological bias Can lead the Cochrane collaboration to irrelevance in
public health decision-making. PLoS Negl Trop Dis. 2015;9:e0004165.
66. Hotez PJ. Empowering women and improving female reproductive health
through control of neglected tropical diseases. PLoS Negl Trop Dis. 2009;3:e559.
67. Huang Y-X, Manderson L. The social and economic context and
determinants of schistosomiasis japonica. Acta Trop. 2005;96:223–31.
68. Choffnes ER, Relman DA, Institute of Medicine (U.S.). The causes and
impacts of neglected tropical and zoonotic diseases: opportunities for
integrated intervention strategies: workshop summary. Washington, D.C:
National Academies Press; 2011.
69. Kjetland EF, Leutscher PDC, Ndhlovu PD. A review of female genital
schistosomiasis. Trends Parasitol. 2012;28:58–65.
70. Mbabazi PS, Andan O, Fitzgerald DW, Chitsulo L, Engels D, Downs JA.
Examining the relationship between urogenital schistosomiasis and HIV
infection. PLoS Negl Trop Dis. 2011;5:e1396.
71. Hotez P, Whitham M. Helminth infections: a new global women’s health
agenda. Obstet Gynecol. 2014;123:155–60.
72. Ajanga A, Lwambo NJS, Blair L, Nyandindi U, Fenwick A, Brooker S.
Schistosoma mansoni in pregnancy and associations with anaemia in
northwest Tanzania. Trans R Soc Trop Med Hyg. 2006;100:59–63.
73. Friedman JF, Mital P, Kanzaria HK, Olds GR, Kurtis JD. Schistosomiasis and
pregnancy. Trends Parasitol. 2007;23:159–64.
74. Kjetland EF, Mduluza T, Ndhlovu PD, Gomo E, Gwanzura L, Midzi N, et al.
Genital schistosomiasis in women: a clinical 12-month in vivo study
following treatment with praziquantel. Trans R Soc Trop Med Hyg.
2006;100:740–52.
75. Poggensee G, Kiwelu I, Weger V, Göppner D, Diedrich T, Krantz I, et al.
Female genital schistosomiasis of the lower genital tract: prevalence and
disease-associated morbidity in northern Tanzania. J Infect Dis.
2000;181:1210–3.
76. Brooker S, Hotez PJ, Bundy DAP. Hookworm-related anaemia among
pregnant women: a systematic review. PLoS Negl Trop Dis. 2008;2:e291.
77. Machado CR, Machado ES, Rohloff RD, Azevedo M, Campos DP, de Oliveira
RB, et al. Is pregnancy associated with severe dengue? A review of data
from the Rio de Janeiro surveillance information system. PLoS Negl Trop
Dis. 2013;7:e2217.
78. Martines RB, Bhatnagar J, de Oliveira Ramos AM, Davi HPF, Iglezias SD,
Kanamura CT, et al. Pathology of congenital Zika syndrome in Brazil: a case
series. Lancet Lond Engl. 2016;388:898–904.
79. Peter H, Aksoy S. Will Zika become the 2016 NTD of the Year? PLoS Speak
Med. 2016. http://blogs.plos.org/speakingofmedicine/2016/01/07/will-zika-
become-the-2016-ntd-of-the-year/. Accessed 11 Mar 2016.
80. Sesti-Costa R, Silva JS, Gutierrez FRS. Congenital Chagas disease: time to
screen pregnant women? Expert Rev Anti Infect Ther. 2012;10:1279–82.
81. Roberts T, Gravett CA, Velu PP, Theodoratou E, Wagner TA, Zhang JSF, et al.
Epidemiology and aetiology of maternal parasitic infections in low- and
middle-income countries. J Glob Health. 2011;1:189–200.
82. Brooker S, Akhwale W, Pullan R, Estambale B, Clarke SE, Snow RW, et al.
Epidemiology of plasmodium-helminth co-infection in Africa: populations at
risk, potential impact on anemia, and prospects for combining control. Am
J Trop Med Hyg. 2007;77(6 Suppl):88–98.
83. Christian P, Khatry SK, West KP. Antenatal anthelmintic treatment,
birthweight, and infant survival in rural Nepal. Lancet Lond Engl.
2004;364:981–3.
84. Worrell C, Mathieu E. Drug coverage surveys for neglected tropical diseases:
10 years of field experience. Am J Trop Med Hyg. 2012;87:216–22.
85. Rilkoff H, Tukahebwa EM, Fleming FM, Leslie J, Cole DC. Exploring gender
dimensions of treatment programmes for neglected tropical diseases in
Uganda. PLoS Negl Trop Dis. 2013;7:e2312.
86. CDI Study Group. Community-directed interventions for priority health
problems in Africa: results of a multicountry study. Bull World Health Organ.
2010;88:509–18.
87. Vouking MZ, Tamo VC, Tadenfok CN. Contribution and performance of
female Community-Directed Distributors in the treatment of onchocerciasis
with Ivermectin in Sub-Saharan Africa: a systematic review. Pan Afr Med J.
2015;20:188.
88. World Health Organization. Tracking universal health coverage: first global
monitoring report. Geneva: World Health Organization; 2015.
89. Bain R, Cronk R, Wright J, Yang H, Slaymaker T, Bartram J. Fecal
contamination of drinking-water in Low- and middle-income countries: a
systematic review and meta-analysis. PLoS Med. 2014;11:e1001644.
90. Kar K, Chambers R, Plan UK. Handbook on community-led total sanitation.
London: Plan UK; 2008.
91. Castro MC, Kanamori S, Kannady K, Mkude S, Killeen GF, Fillinger U. The
importance of drains for the larval development of lymphatic filariasis and
malaria vectors in Dar es Salaam, United Republic of Tanzania. PLoS Negl
Trop Dis. 2010;4:e693.
92. Kirby MJ, West P, Green C, Jasseh M, Lindsay SW. Risk factors for house-
entry by culicine mosquitoes in a rural town and satellite villages in The
Gambia. Parasit Vectors. 2008;1:41.
93. Chitolina RF, Anjos FA, Lima TS, Castro EA, Costa-Ribeiro MCV. Raw sewage
as breeding site to Aedes (Stegomyia) aegypti (Diptera, culicidae). Acta
Trop. 2016;164:290–6.
94. Emerson PM, Burton M, Solomon AW, Bailey R, Mabey D. The SAFE strategy
for trachoma control: Using operational research for policy, planning and
implementation. Bull World Health Organ. 2006;84:613–9.
95. Sangodoyin AY, Ayotamuno MJ. Guinea worm control: assessing the
effectiveness of drum-lined water holes. Environmentalist. 1990;10:165–76.
96. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. Schistosomiasis and
water resources development: systematic review, meta-analysis, and
estimates of people at risk. Lancet Infect Dis. 2006;6:411–25.
97. Heijnen M, Cumming O, Peletz R, Chan GK-S, Brown J, Baker K, et al. Shared
sanitation versus individual household latrines: a systematic review of health
outcomes. PLoS One. 2014;9:e93300.
98. Grimes JET, Croll D, Harrison WE, Utzinger J, Freeman MC, Templeton MR.
The relationship between water, sanitation and schistosomiasis: a systematic
review and meta-analysis. PLoS Negl Trop Dis. 2014;8:e3296.
99. Stocks ME, Ogden S, Haddad D, Addiss DG, McGuire C, Freeman MC. Effect
of water, sanitation, and hygiene on the prevention of trachoma: a
systematic review and meta-analysis. PLoS Med. 2014;11:e1001605.
100. Strunz EC, Addiss DG, Stocks ME, Ogden S, Utzinger J, Freeman MC. Water,
sanitation, hygiene, and soil-transmitted helminth infection: a systematic
review and meta-analysis. PLoS Med. 2014;11:e1001620.
101. World Health Organization. Water sanitation and hygiene for accelerating
and sustaining progress on neglected tropical diseases. A global strategy
2015–2020. 2015.
102. Remais J, Chen L, Seto E. Leveraging rural energy investment for parasitic
disease control: schistosome ova inactivation and energy co-benefits of
anaerobic digesters in rural China. PLoS One. 2009;4:e4856.
103. Hawdon JM. Controlling soil-transmitted helminths: time to think inside the
box? J Parasitol. 2014;100:166–88.
104. Southgate VR. Schistosomiasis in the Senegal River Basin: before and after
the construction of the dams at Diama, Senegal and Manantali, Mali and
future prospects. J Helminthol. 1997;71:125–32.
105. N’Goran EK, Diabate S, Utzinger J, Sellin B. Changes in human
schistosomiasis levels after the construction of two large hydroelectric dams
in central Côte d’Ivoire. Bull World Health Organ. 1997;75:541–5.
106. Ziegler AD, Petney TN, Grundy-Warr C, Andrews RH, Baird IG, Wasson RJ, et
al. Dams and disease triggers on the lower Mekong river. PLoS Negl Trop
Dis. 2013;7:e2166.
107. Van den Broeck F, Maes GE, Larmuseau MHD, Rollinson D, Sy I, Faye D, et al.
Reconstructing colonization dynamics of the human parasite Schistosoma
mansoni following anthropogenic environmental changes in northwest
Senegal. PLoS Negl Trop Dis. 2015;9:e0003998.
108. Adewale B, Mafe MA, Oyerinde JP. Infectivity and transmission dynamics of
simulium damnosum s. 1 around Owena dam (Ondo State). West Afr J Med.
1999;18:257–60.
109. Dumas D, Mietton M, Hamerlynck O, Pesneaud F, Kane A, Coly A, et al.
Large Dams and Uncertainties: The Case of the Senegal River (West Africa).
Soc Nat Resour. 2010;23:1108–22.
Bangert et al. Infectious Diseases of Poverty  (2017) 6:73 Page 18 of 20
110. Conteh L, Engels T, Molyneux DH. Socioeconomic aspects of neglected
tropical diseases. Lancet. 2010;375:239–47.
111. Hotez PJ. Stigma: the stealth weapon of the NTD. PLoS Negl Trop Dis.
2008;2:e230.
112. Hotez PJ, Ferris MT. The antipoverty vaccines. Vaccine. 2006;24:5787–99.
113. Gilgen DD, Mascie-Taylor CG, Rosetta LL. Intestinal helminth infections,
anaemia and labour productivity of female tea pluckers in Bangladesh. Trop
Med Int Health TM IH. 2001;6:449–57.
114. Sauerborn R, Adams A, Hien M. Household strategies to cope with the
economic costs of illness. Soc Sci Med 1982. 1996;43:291–301.
115. Ton TGN, Mackenzie C, Molyneux DH. The burden of mental health in
lymphatic filariasis. Infect Dis Poverty. 2015;4. doi:10.1186/s40249-015-0068-7.
116. Ramaiah KD, Das PK, Michael E, Guyatt HL. The economic burden of
lymphatic filariasis in India. Parasitol Today. 2000;16:251–3.
117. Hampson K, Coudeville L, Lembo T, Sambo M, Kieffer A, Attlan M, et al.
Estimating the global burden of endemic canine rabies. PLoS Negl Trop Dis.
2015;9:e0003709.
118. Shepard DS, Coudeville L, Halasa YA, Zambrano B, Dayan GH. Economic
impact of dengue illness in the Americas. Am J Trop Med Hyg. 2011;84:200–7.
119. Bleakley H. Disease and development: evidence from hookworm eradication
in the American South. Q J Econ. 2007;122:73–117.
120. Kamel MI, Ghafar YA, Foda N, Khashab S. Impact of type and stage of
schistosomiasis on quality of life and productivity of infected workers. J
Egypt Soc Parasitol. 2001;31:153–67.
121. Canning D. Priority setting and the “neglected” tropical diseases. Trans R
Soc Trop Med Hyg. 2006;100:499–504.
122. Ramaiah KD, Ottesen EA. Progress and impact of 13 years of the global
programme to eliminate lymphatic filariasis on reducing the burden of
filarial disease. PLoS Negl Trop Dis. 2014;8:e3319.
123. de Vlas SJ, Stolk WA, le Rutte EA, Hontelez JAC, Bakker R, Blok DJ, et al.
Concerted efforts to control or eliminate neglected tropical diseases: How
much health will Be gained? PLoS Negl Trop Dis. 2016;10:e0004386.
124. Homeida M, Braide E, Elhassan E, Amazigo UV, Liese B, Benton B, et al.
APOC’s strategy of community-directed treatment with ivermectin (CDTI)
and its potential for providing additional health services to the poorest
populations. African Programme for Onchocerciasis Control. Ann Trop Med
Parasitol. 2002;96 Suppl 1:S93–104.
125. Uniting to Combat NTDs. The neglected tropical diseases supply chain
forum: past, present and future. London: United to Combat NTDs; 2016.
126. Njelesani J, Dacombe R, Palmer T, Smith H, Koudou B, Bockarie M, et al. A
systematic approach to capacity strengthening of laboratory systems for
control of neglected tropical diseases in Ghana, Kenya, Malawi and Sri
Lanka. PLoS Negl Trop Dis. 2014;8:e2736.
127. Bates I, Taegtmeyer M, Squire SB, Ansong D, Nhlema-Simwaka B, Baba A, et
al. Indicators of sustainable capacity building for health research: analysis of
four African case studies. Health Res Policy Syst. 2011;9:14.
128. Katabarwa MN, Habomugisha P, Richards FO, Hopkins D. Community-
directed interventions strategy enhances efficient and effective integration
of health care delivery and development activities in rural disadvantaged
communities of Uganda. Trop Med Int Health TM IH. 2005;10:312–21.
129. World Health Organization. Research and Development to Meet
Health Needs in Developing Countries: Strengthening Global
Financing and Coordination. 2012. http://www.who.int/phi/CEWG_
Report_5_April_2012.pdf?ua=1. Accessed 11 Mar 2016.
130. Kariuki T, Phillips R, Njenga S, Olesen OF, Klatser PR, Porro R, et al. Research
and capacity building for control of neglected tropical diseases: the need
for a different approach. PLoS Negl Trop Dis. 2011;5:e1020.
131. O’Neill HG, Mzilahowa T, de Deus N, Njenga SM, Mmbaga EJ, Kariuki TM.
Evaluation of the european foundation initiative into African research in
neglected tropical diseases by the African fellows. PLoS Negl Trop Dis.
2013;7:e2019.
132. Houweling TAJ, Karim-Kos HE, Kulik MC, Stolk WA, Haagsma JA, Lenk EJ, et
al. Socioeconomic inequalities in neglected tropical diseases: a systematic
review. PLoS Negl Trop Dis. 2016;10:e0004546.
133. Gabrie JA, Rueda MM, Canales M, Gyorkos TW, Sanchez AL. School hygiene
and deworming are key protective factors for reduced transmission of soil-
transmitted helminths among schoolchildren in Honduras. Parasit Vectors.
2014;7:354.
134. Ugbomoiko US, Dalumo V, Ofoezie IE, Obiezue RNN. Socio-environmental
factors and ascariasis infection among school-aged children in Ilobu, Osun
State, Nigeria. Trans R Soc Trop Med Hyg. 2009;103:223–8.
135. Habtamu E, Wondie T, Aweke S, Tadesse Z, Zerihun M, Zewdie Z, et al.
Trachoma and relative poverty: a case–control study. PLoS Negl Trop Dis.
2015;9:e0004228.
136. Albuquerque PLMM, da Silva Júnior GB, Freire CCF, de Oliveira SBC, Almeida
DM, da Silva HF, et al. Urbanization of visceral leishmaniasis (kala-azar) in
Fortaleza, Ceará, Brazil. Rev Panam Salud Publica. 2009;26:330–3.
137. Neiderud C-J. How urbanization affects the epidemiology of emerging
infectious diseases. Infect Ecol Epidemiol. 2015;5. doi:10.3402/iee.v5.27060.
138. Carrillo E, Moreno J, Cruz I. What is responsible for a large and unusual
outbreak of leishmaniasis in Madrid? Trends Parasitol. 2013;29:579–80.
139. Fernandez-Garcia MD, Bangert M, de Ory F, Potente A, Hernandez L, Lasala
F, et al. Chikungunya virus infections among travellers returning to Spain,
2008 to 2014. Eurosurveillance. 2016;21. doi:10.2807/1560-7917.ES.
2016.21.36.30336.
140. Galvan JM. Growing burden of dengue in Latin America: a public health
challenge. Int J Infect Dis. 2010;14:e169.
141. Kikuti M, Cunha GM, Paploski IAD, Kasper AM, Silva MMO, Tavares AS,
et al. Spatial distribution of dengue in a Brazilian urban slum setting:
role of socioeconomic gradient in disease risk. PLoS Negl Trop Dis.
2015;9:e0003937.
142. Sommerfeld J, Kroeger A. Innovative community-based vector control
interventions for improved dengue and Chagas disease prevention in Latin
America: introduction to the special issue. Trans R Soc Trop Med Hyg.
2015;109:85–8.
143. Levy MZ, Barbu CM, Castillo-Neyra R, Quispe-Machaca VR, Ancca-Juarez J,
Escalante-Mejia P, et al. Urbanization, land tenure security and vector-borne
Chagas disease. Proc R Soc B Biol Sci. 2014;281:20141003.
144. Dias JCP. Southern Cone Initiative for the elimination of domestic
populations of Triatoma infestans and the interruption of transfusional
Chagas disease. Historical aspects, present situation, and perspectives. Mem
Inst Oswaldo Cruz. 2007;102 Suppl 1:11–8.
145. Dias JCP, Silveira AC, Schofield CJ. The impact of Chagas disease control in
Latin America: a review. Mem Inst Oswaldo Cruz. 2002;97:603–12.
146. Rojas-De-Arias A. Chagas disease prevention through improved housing
using an ecosystem approach to health. Cad Saude Publica.
2001;17(Suppl):89–97.
147. Hemingway J, Ranson H, Magill A, Kolaczinski J, Fornadel C, Gimnig J, et al.
Averting a malaria disaster: will insecticide resistance derail malaria control?
Lancet. 2016;387:1785–8.
148. Vontas J, Kioulos E, Pavlidi N, Morou E, della Torre A, Ranson H. Insecticide
resistance in the major dengue vectors Aedes albopictus and Aedes
aegypti. Pestic Biochem Physiol. 2012;104:126–31.
149. Ranson H, Burhani J, Lumjuan N, Black IV WC. Insecticide resistance in
dengue vectors. TropIKAnet. 2010;1:0.
150. World Health Organization. WHO pesticide evaluation scheme: 50 years of
global leadership. Geneva: United to Combat NTDs; 2010.
151. Roiz D, Eritja R, Escosa R, Lucientes J, Marquès E, Melero-Alcíbar R, et al. A
survey of mosquitoes breeding in used tires in Spain for the detection of
imported potential vector species. J Vector Ecol J Soc Vector Ecol.
2007;32:10–5.
152. Reiter P, Sprenger D. The used tire trade: a mechanism for the worldwide
dispersal of container breeding mosquitoes. J Am Mosq Control Assoc.
1987;3:494–501.
153. World Health Organization. Dengue: guidelines for diagnosis, treatment,
prevention and control. World Health Organization; 2009.
154. Banerjee S, Aditya G, Saha GK. Household wastes as larval habitats of
dengue vectors: comparison between urban and rural areas of Kolkata,
India. PLoS ONE. 2015;10:e0138082.
155. McCarthy JJ, Intergovernmental Panel on Climate Change. Climate change
2001: impacts, adaptation, and vulnerability: contribution of Working Group
II to the third assessment report of the Intergovernmental Panel on Climate
Change. Cambridge, UK. New York: Cambridge University Press; 2001.
156. Naish S, Dale P, Mackenzie JS, McBride J, Mengersen K, Tong S. Climate change
and dengue: a critical and systematic review of quantitative modelling
approaches. BMC Infect Dis. 2014;14. doi:10.1186/1471-2334-14-167.
157. Trewin BJ, Kay BH, Darbro JM, Hurst TP. Increased container-breeding
mosquito risk owing to drought-induced changes in water harvesting and
storage in Brisbane, Australia. Int Health. 2013;5:251–8.
158. Garza M, Feria Arroyo TP, Casillas EA, Sanchez-Cordero V, Rivaldi C-L, Sarkar
S. Projected future distributions of vectors of Trypanosoma cruzi in North
America under climate change scenarios. PLoS Negl Trop Dis. 2014;8:e2818.
Bangert et al. Infectious Diseases of Poverty  (2017) 6:73 Page 19 of 20
159. Dujardin J-C, Campino L, Cañavate C, Dedet J-P, Gradoni L, Soteriadou K, et
al. Spread of vector-borne diseases and neglect of leishmaniasis. Europe
Emerg Infect Dis. 2008;14:1013–8.
160. Patz JA, Hahn MB. Climate change and human health: a One Health
approach. Curr Top Microbiol Immunol. 2013;366:141–71.
161. Semenza JC, Sudre B, Oni T, Suk JE, Giesecke J. Linking environmental
drivers to infectious diseases: the european environment and epidemiology
network. PLoS Negl Trop Dis. 2013;7:e2323.
162. Nichols GL, Andersson Y, Lindgren E, Devaux I, Semenza JC. European
monitoring systems and data for assessing environmental and climate
impacts on human infectious diseases. Int J Environ Res Public Health.
2014;11:3894–936.
163. McIntyre PB, Reidy Liermann CA, Revenga C. Linking freshwater fishery
management to global food security and biodiversity conservation. Proc
Natl Acad Sci. 2016.
164. Chai J-Y, Darwin Murrell K, Lymbery AJ. Fish-borne parasitic zoonoses: status
and issues. Int J Parasitol. 2005;35:1233–54.
165. Keiser J, Utzinger J. Food-borne trematodiases. Clin Microbiol Rev.
2009;22:466–83.
166. Keiser J, Utzinger J. Emerging foodborne trematodiasis. Emerg Infect Dis.
2005;11:1507–14.
167. Bartoli P, Boudouresque CF. Effect of the digenean parasites of fish on the
fauna of Mediterranean lagoons. Parassitologia. 2007;49:111–7.
168. Phan VT, Ersbøll AK, Nguyen KV, Madsen H, Dalsgaard A. Farm-level risk
factors for fish-borne zoonotic trematode infection in integrated small-scale
fish farms in northern Vietnam. PLoS Negl Trop Dis. 2010;4:e742.
169. Hedegaard Clausen J, Madsen H, Murrell KD, Van PT, Thu HNT, Do DT, et al.
Prevention and control of fish-borne zoonotic trematodes in fish nurseries,
Vietnam. Emerg Infect Dis. 2012;18:1438–45.
170. Madsen H, Thien PC, Nga HTN, Clausen JH, Dalsgaard A, Murrell KD. Two-
year intervention trial to control of fish-borne zoonotic trematodes in giant
gourami (Osphronemus goramy) and striped catfish (Pangasianodon
hypophthalmus) in nursery ponds in the Mekong Delta. Vietnam Acta Trop.
2015;152:201–7.
171. Molyneux DH. Common themes in changing vector-borne disease
scenarios. Trans R Soc Trop Med Hyg. 2003;97:129–32.
172. World Trade Organization. Factors shaping the future of world trade.
Geneva: United to Combat NTDs; 2013.
173. Molyneux DH. Vector-borne infections in the tropics and health policy
issues in the twenty-first century. Trans R Soc Trop Med Hyg. 2001;95:233–8.
174. Walsh JF, Molyneux DH, Birley MH. Deforestation: effects on vector-borne
disease. Parasitology. 1993;106(Suppl):S55–75.
175. Wilcox BA, Ellis B. Forests and emerging infectious diseases of humans.
Unasylva. 2006;57:11-18.
176. Kat PW, Alexander KA, Smith JS, Munson L. Rabies and African wild dogs in
Kenya. Proc Biol Sci. 1995;262:229–33.
177. Tangena J-AA, Thammavong P, Wilson AL, Brey PT, Lindsay SW. Risk and
control of mosquito-borne diseases in southeast Asian rubber plantations.
Trends Parasitol. 2016;32:402–15.
178. Hotez PJ, Bethony J, Bottazzi ME, Brooker S, Buss P. Hookworm: “The Great
Infection of Mankind.”. PLoS Med. 2005;2:e67.
179. Prüss-Üstün A, Corvalán C. Preventing disease through healthy
environments: towards an estimate of the environmental burden of disease.
Geneva: World Health Organization; 2006.
180. Wong MS, Bundy DA. Quantitative assessment of contamination of soil by
the eggs of Ascaris lumbricoides and Trichuris trichiura. Trans R Soc Trop
Med Hyg. 1990;84:567–70.
181. Schmidlin T, Hürlimann E, Silué KD, Yapi RB, Houngbedji C, Kouadio BA, et
al. Effects of hygiene and defecation behavior on helminths and intestinal
protozoa infections in taabo, Côte d’Ivoire. PLoS ONE.
2013;8:e65722.
182. Humphreys G. Reinventing the toilet for 2.5 billion in need. Bull World
Health Organ. 2014;92:470–1.
183. The Lancet Infectious Diseases. Guinea worm disease nears eradication.
Lancet Infect Dis. 2016;16:131.
184. Molyneux DH. Control of human parasitic diseases: context and overview.
In: Advances in Parasitology. Elsevier; 2006. p. 1–45. http://linkinghub.
elsevier.com/retrieve/pii/S0065308X05610019. Accessed 20 Oct 2016.
185. Al-Salem WS, Pigott DM, Subramaniam K, Haines LR, Kelly-Hope L, Molyneux
DH, et al. Cutaneous leishmaniasis and conflict in Syria. Emerg Infect Dis.
2016;22:931–3.
186. Alawieh A, Musharrafieh U, Jaber A, Berry A, Ghosn N, Bizri AR. Revisiting
leishmaniasis in the time of war: the Syrian conflict and the Lebanese
outbreak. Int J Infect Dis. 2014;29:115–9.
187. Al-Salem W, Herricks JR, Hotez PJ. A review of visceral leishmaniasis during
the conflict in South Sudan and the consequences for East African
countries. Parasit Vectors. 2016;9:460. doi:10.1186/s13071-016-1743-7.
188. Tsutsumi A, Izutsu T, Md Islam A, Maksuda AN, Kato H, Wakai S. The quality
of life, mental health, and perceived stigma of leprosy patients in
Bangladesh. Soc Sci Med. 2007;64:2443–53.
189. Vlassoff C, Weiss M, Ovuga EB, Eneanya C, Nwel PT, Babalola SS, et al.
Gender and the stigma of onchocercal skin disease in Africa. Soc Sci Med.
2000;50:1353–68.
190. Debacker M, Aguiar J, Steunou C, Zinsou C, Meyers WM, Portaels F. Buruli
ulcer recurrence. Benin Emerg Infect Dis. 2005;11:584–9.
191. Kassi M, Kassi M, Afghan AK, Rehman R, Kasi PM. Marring leishmaniasis: the
stigmatization and the impact of cutaneous leishmaniasis in Pakistan and
Afghanistan. PLoS Negl Trop Dis. 2008;2:e259.
192. Takougang I, Meli J, Fotso S, Angwafo F, Kamajeu R, Ndumbe PM. Some
social determinants of urinary schistosomiasis in Northern Cameroon :
implications for schistosomiasis control. Afr J Health Sci. 2005;11. doi:10.
4314/ajhs.v11i3.30788.
193. Ventura-Garcia L, Roura M, Pell C, Posada E, Gascón J, Aldasoro E, et al.
Socio-cultural aspects of Chagas disease: a systematic review of qualitative
research. PLoS Negl Trop Dis. 2013;7:e2410.
194. Hofstraat K, van Brakel WH. Social stigma towards neglected tropical
diseases: a systematic review. Int Health. 2016;8 Suppl 1:i53–70.
195. Liese B, Rosenberg M, Schratz A. Programmes, partnerships, and governance
for elimination and control of neglected tropical diseases. Lancet.
2010;375:67–76.
196. Bush S, Hopkins AD. Public-private partnerships in neglected tropical
disease control: the role of nongovernmental organisations. Acta Trop.
2011;120 Suppl 1:S169–72.
197. Leslie J, Garba A, Boubacar K, Yayé Y, Sebongou H, Barkire A, et al.
Neglected tropical diseases: comparison of the costs of integrated and
vertical preventive chemotherapy treatment in Niger. Int Health.
2013;5:78–84.
198. Sinuon M, Tsuyuoka R, Socheat D, Montresor A, Palmer K. Financial costs of
deworming children in all primary schools in Cambodia. Trans R Soc Trop
Med Hyg. 2005;99:664–8.
199. Goldman AS, Guisinger VH, Aikins M, Amarillo MLE, Belizario VY, Garshong B,
et al. National mass drug administration costs for lymphatic filariasis
elimination. PLoS Negl Trop Dis. 2007;1:e67.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Bangert et al. Infectious Diseases of Poverty  (2017) 6:73 Page 20 of 20
